<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0066">
    <title>49 Francisella*</title>
    <sect1 id="ch0066s0001">
      <title>49 Francisella*</title>
      <anchor id="ch0066s0001a0001"/>
      <anchor id="ch0066s0000a0001"/>
      <anchor id="ch0066s0000a0002"/>
      <para role="chapterAuthor"><phrase role="center">ELIZABETH A. DIETRICH AND JEANNINE M. PETERSEN</phrase>
      </para>
      <para id="ch0066s0000p0001"><emphasis>Francisella tularensis</emphasis> is the causative agent of tularemia, an acute and fatal illness in animals and humans. Human infections caused by <emphasis>F. tularensis</emphasis> occur via arthropod bite, handling of infected animals, inhalation of infectious aerosols, and ingestion of contaminated food or water. <emphasis>F. tularensis</emphasis> is highly infectious, with 10 organisms being sufficient to cause illness, and therefore poses a serious risk for laboratory-acquired infections. It has been studied as a potential biological weapon and is one of six bacterial agents classified by the United States government as Tier 1 select agents, considered to present the greatest risk of deliberate misuse with the most significant potential for mass casualties or devastating effects to the economy, critical infrastructure, or public confidence.</para>
      <para id="ch0066s0000p0002">Within the genus<emphasis>Francisella, F. tularensis</emphasis> is joined by several lesser-known <emphasis>Francisella</emphasis> species which are largely environmental organisms. <emphasis>F. novicida, F. philomiragia, F. hispaniensis</emphasis>, and <emphasis>F. opportunistica</emphasis> cause rare opportunistic infections in immunocompromised individuals. Other <emphasis>Francisella</emphasis> species include pathogens of aquatic organisms, environmental bacteria isolated from aquatic environments, and tick endosymbionts.</para>
      <sect2 id="ch0066s0001s0001">
        <title>TAXONOMY</title>
        <anchor id="ch0066s0001a0002"/>
        <anchor id="ch0066s0000a0003"/>
        <para id="ch0066s0000p0003">The family<emphasis>Francisellaceae</emphasis> belongs to the order <emphasis>Thiotrichales</emphasis> and the gamma subclass of proteobacteria. The family currently consists of three genera: <emphasis>Francisella, Allofrancisella</emphasis>, and <emphasis>Pseudofrancisella. Allofrancisella</emphasis> and <emphasis>Pseudofrancisella</emphasis> spp. are environmental organisms that have not been associated with disease and are not considered further in this chapter (<link linkend="ch0066s0000li0001">1</link>, <link linkend="ch0066s0000li0002">2</link>). Several publications have reviewed the history and descriptions of members of the genus <emphasis>Francisella</emphasis> (<link linkend="ch0066s0000li0003">3</link>–<link linkend="ch0066s0000li0005">5</link>). The genus currently consists of <emphasis>F. tularensis, F. novicida, F. philomiragia, F. hispaniensis, F. opportunistica, F. noatunensis, F. orientalis, F. halioticida, F. salimarina</emphasis>, and <emphasis>F. persica</emphasis>, as well as unclassified <emphasis>Francisella</emphasis> spp. (<ulink url="https://www.bacterio.net/genus/francisella">https://www.bacterio.net/genus/francisella</ulink>).</para>
        <para id="ch0066s0000p0004"><emphasis>F. tularensis</emphasis>, the species of main clinical significance, is the causative agent of tularemia, a zoonosis affecting humans and a wide range of animals. The bacterium was first isolated from squirrels suffering a “plague-like” illness in Tulare County, California. Three subspecies of <emphasis>F. tularensis, F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> (type A), <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> (type B), and <emphasis>F. tularensis</emphasis> subsp. <emphasis>mediasiatica</emphasis>, are recognized, with ≥99.2% average nucleotide identity (ANI) across 1.1 Mb of genome sequence (<link linkend="ch0066s0000li0006">6</link>).</para>
        <para id="ch0066s0000p0005"><emphasis>F. novicida</emphasis> and <emphasis>F. philomiragia</emphasis> were originally isolated from saltwater sources and are genetically, biochemically, and serologically distinct from <emphasis>F. tularensis</emphasis>, in addition to having reduced virulence (<link linkend="ch0066s0000li0006">6</link>–<link linkend="ch0066s0000li0008">8</link>). <emphasis>F. philomiragia</emphasis> is relatively phylogenetically distant from <emphasis>F. tularensis</emphasis>, and the two genomes display &lt;83% ANI (<link linkend="ch0066s0000li0005">5</link>, <link linkend="ch0066s0000li0009">9</link>). A high degree of genetic similarity exists between <emphasis>F. novicida</emphasis> and <emphasis>F. tularensis</emphasis>, and on this basis, <emphasis>F. novicida</emphasis> was proposed as a fourth subspecies of <emphasis>F. tularensis</emphasis> (<link linkend="ch0066s0000li0010">10</link>, <link linkend="ch0066s0000li0011">11</link>). Whole-genome comparisons, however, provide evidence that <emphasis>F. novicida</emphasis> and <emphasis>F. tularensis</emphasis> evolved as two distinct population lineages, consistent with <emphasis>F. novicida</emphasis> and <emphasis>F. tularensis</emphasis> being two separate species (<link linkend="ch0066s0000li0006">6</link>, <link linkend="ch0066s0000li0007">7</link>, <link linkend="ch0066s0000li0012">12</link>). Clinical and ecological differences between <emphasis>F. tularensis</emphasis> and <emphasis>F. novicida</emphasis> also indicate that the two represent distinct species (<link linkend="ch0066s0000li0007">7</link>, <link linkend="ch0066s0000li0012">12</link>) (see “Epidemiology and Transmission” and “Clinical Significance” below).</para>
        <para id="ch0066s0000p0006"><emphasis>F. hispaniensis</emphasis> is a rare opportunistic pathogen that has been isolated from human cases in Spain, Australia, and China (<link linkend="ch0066s0000li0011">11</link>, <link linkend="ch0066s0000li0013">13</link>–<link linkend="ch0066s0000li0016">16</link>). <emphasis>F. hispaniensis</emphasis> genomes show approximately 90% ANI with genomes of both <emphasis>F. tularensis</emphasis> and <emphasis>F. novicida</emphasis> and approximately 83% ANI with <emphasis>F. philomiragia</emphasis> (<link linkend="ch0066s0000li0009">9</link>). <emphasis>F. opportunistica</emphasis> has been isolated in culture from three immunocompromised patients in the United States and displays approximately 87% ANI to <emphasis>F. tularensis, F. novicida</emphasis>, and <emphasis>F. hispaniensis</emphasis> genomes (<link linkend="ch0066s0000li0017">17</link>).</para>
        <para id="ch0066s0000p0007"><emphasis>F. noatunensis, F. orientalis</emphasis>, and <emphasis>F. halioticida</emphasis> are pathogens of saltwater fish species and giant abalone (<link linkend="ch0066s0000li0018">18</link>–<link linkend="ch0066s0000li0020">20</link>). These species cluster phylogenetically with <emphasis>F. philomiragia</emphasis> (<link linkend="ch0066s0000li0005">5</link>). Other isolates have been derived from aquatic sources, including seawater and cooling towers (<link linkend="ch0066s0000li0009">9</link>, <link linkend="ch0066s0000li0021">21</link>). <emphasis>F. persica</emphasis>, an endosymbiont of ticks, was formerly known as <emphasis>Wolbachia persica</emphasis>, but was reassigned to the genus <emphasis>Francisella</emphasis> based on sequence analysis (<link linkend="ch0066s0000li0022">22</link>). The <emphasis>F. persica</emphasis> genome has a reduced gene content, consistent with its status as an endosymbiont (<link linkend="ch0066s0000li0009">9</link>, <link linkend="ch0066s0000li0022">22</link>). Other <emphasis>Francisella</emphasis>-like endosymbionts have been identified in a variety of tick species by sequence analysis but have not been cultured or assigned formal taxonomic status (<link linkend="ch0066s0000li0003">3</link>, <link linkend="ch0066s0000li0023">23</link>).</para>
        <anchor id="ch0066s0000a0004"/>
        <beginpage pagenum="960"/>
        <table id="ch0066s0000t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0066s0000a0005"/><link linkend="ch0066s0000a0011">TABLE 1</link></phrase></emphasis> Differentiation of <emphasis>F. tularensis</emphasis> from similar Gram-negative bacteria<superscript><emphasis><anchor id="ch0066s0000a0006"/><link linkend="ch0066s0000a0008">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="7">
            <tbody>
              <row>
                <entry><phrase role="left">Test</phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>F. tularensis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center"><emphasis>Brucella</emphasis> spp.</phrase>
                </entry>
                <entry><phrase role="center"><emphasis>Acinetobacter</emphasis> spp.</phrase>
                </entry>
                <entry><phrase role="center"><emphasis>Haemophilus</emphasis> spp.<superscript><emphasis><anchor id="ch0066s0000a0007"/><link linkend="ch0066s0000a0009">b</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>Yersinia pestis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>Pasteurella multocida</emphasis>
                  </phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Oxidase</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Urease</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">≥</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Gram stain morphology</phrase>
                </entry>
                <entry><phrase role="center">Very tiny ccb</phrase>
                </entry>
                <entry><phrase role="center">Tiny ccb</phrase>
                </entry>
                <entry><phrase role="center">Broad ccb</phrase>
                </entry>
                <entry><phrase role="center">Small ccb</phrase>
                </entry>
                <entry><phrase role="center">Small rod</phrase>
                </entry>
                <entry><phrase role="center">Small ccb</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">X and/or V factor requirement</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Cysteine enhancement</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0066s0000a0008"/><link linkend="ch0066s0000a0006">a</link></emphasis></superscript>+, greater than or equal to 90% positive; −, less than or equal to 10% positive; V, variable (11 to 89% positive); ccb, coccobacilli.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0066s0000a0009"/><link linkend="ch0066s0000a0007">b</link></emphasis></superscript><emphasis>Haemophilus</emphasis> spp. requiring X and V factors or V factor only.</para>
      </sect2>
      <sect2 id="ch0066s0001s0002">
        <title>DESCRIPTION OF THE GENUS</title>
        <anchor id="ch0066s0001a0003"/>
        <anchor id="ch0066s0000a0010"/>
        <para id="ch0066s0000p0008"><emphasis>Francisella</emphasis> spp. are tiny Gram-negative coccobacilli which range in size from 0.2 to 1.7 μm. Features distinguishing <emphasis>Francisella</emphasis> from similar genera are shown in <anchor id="ch0066s0000a0011"/><link linkend="ch0066s0000a0005">Table 1</link>. Members of the genus take up Gram counterstain (safranin) poorly; they are strict aerobes, urease negative, nonmotile, and non-spore forming, and they metabolize a limited number of carbohydrates (<anchor id="ch0066s0000a0012"/><link linkend="ch0066s0000a0017">Table 2</link>). Only a few sugars (glucose, maltose, sucrose, and glycerol) are utilized by most members of the genus. Acid is produced without gas. Unique cellular fatty acids are associated with the genus (<link linkend="ch0066s0000li0003">3</link>, <link linkend="ch0066s0000li0010">10</link>). For most species, <emphasis>in vitro</emphasis> growth is enhanced by cysteine supplementation (<link linkend="ch0066s0000li0003">3</link>). A few key differences separate species of the genus <emphasis>Francisella</emphasis>, including growth in nutrient broth with 6% NaCl, optimum growth temperatures, and sugar utilization (<link linkend="ch0066s0000a0017">Table 2</link>). Cultured members of the genus share &gt;95% sequence identity within their 16S rRNA genes (<link linkend="ch0066s0000li0003">3</link>, <link linkend="ch0066s0000li0009">9</link>). Genomes of all clinically relevant members of the genus share &gt;80% ANI, although some environmental species are more distantly related. Genomes of <emphasis>F. tularensis</emphasis> strains within all three subspecies share ANI of &gt;99%. ANI between <emphasis>F. tularensis</emphasis> and <emphasis>F. novicida</emphasis> genomes is approximately 97 to 98% (<link linkend="ch0066s0000li0009">9</link>, <link linkend="ch0066s0000li0017">17</link>).</para>
        <para id="ch0066s0000p0009"><emphasis>F. tularensis</emphasis> is the most virulent <emphasis>Francisella</emphasis> species in mammals. In laboratory mice inoculated subcutaneously or intradermally, a 50% lethal dose (LD<subscript>50</subscript>) of only 1 to 10 cells is observed for <emphasis>F. tularensis</emphasis>, compared with LD<subscript>50</subscript>s ranging from 10 to 10<superscript>7</superscript> cells for <emphasis>F. novicida</emphasis> (<link linkend="ch0066s0000li0007">7</link>). <emphasis>F. philomiragia</emphasis> has an LD<subscript>50</subscript> of 3.45 × 10<superscript>3</superscript> cells when inoculated intranasally into mice (<link linkend="ch0066s0000li0024">24</link>). Levels of virulence also differ between <emphasis>F. tularensis</emphasis> subspecies; <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> displays an LD<subscript>100</subscript> of &lt;10 cells when inoculated subcutaneously into rabbits, compared to an LD<subscript>100</subscript> of 10<superscript>9</superscript> cells for <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> (<link linkend="ch0066s0000li0025">25</link>).</para>
        <para id="ch0066s0000p0010">All<emphasis>Francisella</emphasis> genomes are composed of a single chromosome, which in most cases is <emphasis role="strong">~</emphasis>1.9 Mb with a GC content of <emphasis role="strong">~</emphasis>32%. Whole-genome analyses indicate that <emphasis>F. tularensis</emphasis> contains very few unique genes in comparison to other members of the genus, including <emphasis>F. novicida</emphasis> (<link linkend="ch0066s0000li0005">5</link>). One distinguishing feature of the <emphasis>F. tularensis</emphasis> genome compared to other <emphasis>Francisella</emphasis> genomes is duplication of the <emphasis>Francisella</emphasis> pathogenicity island, which encodes an atypical type VI secretion system required for intracellular growth and virulence (<link linkend="ch0066s0000li0026">26</link>). In all other <emphasis>Francisella</emphasis> genomes sequenced to date, this pathogenicity island is present only in a single copy (<link linkend="ch0066s0000li0009">9</link>, <link linkend="ch0066s0000li0017">17</link>).</para>
      </sect2>
      <sect2 id="ch0066s0001s0003">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0066s0001a0004"/>
        <anchor id="ch0066s0000a0013"/>
        <para id="ch0066s0000p0011"><emphasis>F. tularensis</emphasis> has been recovered primarily in the Northern Hemisphere, with a few reports of <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> in Australia (<link linkend="ch0066s0000li0027">27</link>, <link linkend="ch0066s0000li0028">28</link>) (<anchor id="ch0066s0000a0014"/><link linkend="ch0066s0000a0022">Table 3</link>). The distribution of the subspecies varies throughout the Northern Hemisphere (<link linkend="ch0066s0000li0004">4</link>, <link linkend="ch0066s0000li0023">23</link>, <link linkend="ch0066s0000li0029">29</link>, <link linkend="ch0066s0000li0030">30</link>). Infections caused by <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> occur throughout the Northern Hemisphere, whereas <emphasis>F. tularensis</emphasis> subsp<emphasis>. tularensis</emphasis> is found only in North America. <emphasis>F. tularensis</emphasis> subsp. <emphasis>mediasiatica</emphasis> has been found only in regions of central Asia and Russia (<link linkend="ch0066s0000li0031">31</link>). Within the United States, the <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> A1 (also called A.I) subpopulation predominates in the eastern half of the country, whereas the A2 (A.II) subpopulation appears to be restricted to the western half (<link linkend="ch0066s0000li0032">32</link>–<link linkend="ch0066s0000li0034">34</link>).</para>
        <para id="ch0066s0000p0012">Despite the broad geographic distribution of<emphasis>F. tularensis</emphasis>, overall disease occurrence is suspected to be low (<link linkend="ch0066s0000li0004">4</link>). Foci of endemicity, where incidence may be higher, have long been documented in regions of Russia and Kazakhstan, as well as Finland, Sweden, and the United States (<link linkend="ch0066s0000li0004">4</link>, <link linkend="ch0066s0000li0030">30</link>, <link linkend="ch0066s0000li0035">35</link>). In the United States, the incidence of tularemia is approximately 200 cases each year; detailed statistics are available at <ulink url="http://www.cdc.gov/tularemia/statistics">http://www.cdc.gov/tularemia/statistics</ulink>. All states except Hawaii have reported cases. Tularemia is most commonly reported in the south-central states of Missouri, Arkansas, Kansas, and Oklahoma. In the European Union, an average of approximately 800 cases of tularemia was reported annually from 2012 to 2019 (<link linkend="ch0066s0000li0036">36</link>). Reported cases by country in the European Union can be found at <ulink url="https://ecdc.europa.eu/en/tularaemia/surveillance-and-disease-data/disease-data-atlas">https://ecdc.europa.eu/en/tularaemia/surveillance-and-disease-data/disease-data-atlas</ulink>.</para>
        <para id="ch0066s0000p0013">Tularemia in humans is predominantly a rural disease, and urban cases are rare. Most cases of tularemia occur in the summer months, with patients acquiring<emphasis>F. tularensis</emphasis> infection from tick or deerfly bites or from contact with infected animals (e.g., by skinning rabbits) (<link linkend="ch0066s0000li0004">4</link>). Inhalation of an infective aerosol during landscaping, particularly when mowing over dead rabbits, and contact with infected cats are also potential sources of infection (<link linkend="ch0066s0000li0037">37</link>, <link linkend="ch0066s0000li0038">38</link>). Dogs may carry <emphasis>F. tularensis</emphasis> in their mouths or on their fur, with or without clinical signs, posing a risk to owners who engage in close facial contact (<link linkend="ch0066s0000li0039">39</link>). Tularemia is more commonly reported in males than in females, possibly due to more frequent exposure through hunting and landscaping. Tularemia cases are largely sporadic, and outbreaks of tularemia are rare.</para>
        <para id="ch0066s0000p0014"><emphasis>F. tularensis</emphasis> is a zoonotic pathogen, capable of infecting a large variety of animal species. The bacterium has been isolated from vertebrates, including mammals, amphibians, and birds, as well as from invertebrate arthropods (<link linkend="ch0066s0000li0023">23</link>, <link linkend="ch0066s0000li0040">40</link>). The arthropod vectors most commonly associated with transmission of tularemia to humans in the United States are ticks (<emphasis>Dermacentor</emphasis> spp. and <emphasis>Amblyomma americanum</emphasis>) and deerflies (<emphasis>Chrysops</emphasis> spp.) (<link linkend="ch0066s0000li0041">41</link>). In Sweden and Finland, mosquitoes are the primary arthropod associated with transmission of <emphasis>F. tularensis</emphasis> (<link linkend="ch0066s0000li0041">41</link>, <link linkend="ch0066s0000li0042">42</link>). Among vertebrates, <emphasis>F. tularensis</emphasis> is most commonly associated with rodents and other mammals, particularly hares and rabbits. In both vertebrates and invertebrates, infection with <emphasis>F. tularensis</emphasis> can be lethal.</para>
        <anchor id="ch0066s0000a0015"/>
        <beginpage pagenum="961"/>
        <anchor id="ch0066s0000a0016"/>
        <beginpage pagenum="962"/>
        <table id="ch0066s0000t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0066s0000a0017"/><link linkend="ch0066s0000a0012">TABLE 2</link></phrase></emphasis> Characteristics of <emphasis>Francisella</emphasis> spp.<superscript><emphasis><anchor id="ch0066s0000a0018"/><link linkend="ch0066s0000a0020">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="10">
            <tbody>
              <row>
                <entry><phrase role="center">Characteristic</phrase>
                </entry>
                <entry><phrase role="center"><emphasis>F. tularensis</emphasis> subsp<emphasis>. tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="center"><emphasis>F. tularensis</emphasis> subsp<emphasis>. holarctica</emphasis></phrase>
                </entry>
                <entry><phrase role="center"><emphasis>F. tularensis</emphasis> subsp<emphasis>. mediasiatica</emphasis></phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>F. novicida</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>F. philomiragia</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>F. hispaniensis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>F. opportunistica</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>F. noatunensis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="center">
                    <emphasis>F. halioticida</emphasis>
                  </phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Gram stain (culture)</phrase>
                </entry>
                <entry><phrase role="left">Pleomorphic, single, rarely chained, Gram-negative tiny coccobacilli</phrase>
                </entry>
                <entry><phrase role="left">As for <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="left">As for <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="left">As for <emphasis>F. tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="left">As for <emphasis>F. tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="left">Gram-negative pleomorphic coccobacilli</phrase>
                </entry>
                <entry><phrase role="left">Gram-negative coccobacilli</phrase>
                </entry>
                <entry><phrase role="left">Gram-negative coccobacilli</phrase>
                </entry>
                <entry><phrase role="left">Gram-negative coccobacilli</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Cell size (μm)</phrase>
                </entry>
                <entry><phrase role="left">0.2–0.7 × 0.2</phrase>
                </entry>
                <entry><phrase role="left">0.2–0.7 × 0.2</phrase>
                </entry>
                <entry><phrase role="left">0.2–0.7 × 0.2</phrase>
                </entry>
                <entry><phrase role="left">0.7 × 1.7</phrase>
                </entry>
                <entry><phrase role="left">0.7 × 1.7</phrase>
                </entry>
                <entry><phrase role="left">0.5 × 1.5</phrase>
                </entry>
                <entry><phrase role="left">NT</phrase>
                </entry>
                <entry><phrase role="left">NT</phrase>
                </entry>
                <entry><phrase role="left">0.5–1.0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Growth on blood agar</phrase>
                </entry>
                <entry><phrase role="left">+/−; exogenous cysteine in specimen may allow limited growth</phrase>
                </entry>
                <entry><phrase role="left">+/−; as for <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="left">+/−; as for <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="left">NT; requires 70% artificial seawater for growth on Eugon agar</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">CHAB</phrase>
                </entry>
                <entry><phrase role="left">48 h; colonies are 1–2 mm in diameter, raised, and smooth, with entire margins, green tint, and opalescent sheen</phrase>
                </entry>
                <entry><phrase role="left">As for <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="left">NT</phrase>
                </entry>
                <entry><phrase role="left">48 h; as for <emphasis>F. tularensis</emphasis> but 2–4 mm in diameter</phrase>
                </entry>
                <entry><phrase role="left">48 h; colonies are &gt;4 mm in diameter, creamy white-gray, mucoid, and smooth, with a purple-tinted opalescent sheen</phrase>
                </entry>
                <entry><phrase role="left">48 h; colonies are 3–4 mm in diameter, convex, and pale white to gray</phrase>
                </entry>
                <entry><phrase role="left">48 h; colonies are 1–2 mm in diameter</phrase>
                </entry>
                <entry><phrase role="left">48 h; colonies are ~1 mm in diameter, low, convex, white, slightly translucent, and mucoid</phrase>
                </entry>
                <entry><phrase role="left">10–14 days; colonies are grayish to white, circular, and slightly convex, with entire margins</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Growth in nutrient broth with 6% NaCl</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Optimal growth temperature</phrase>
                </entry>
                <entry><phrase role="left">35–37°C</phrase>
                </entry>
                <entry><phrase role="left">35–37°C</phrase>
                </entry>
                <entry><phrase role="left">35–37°C</phrase>
                </entry>
                <entry><phrase role="left">35–37°C</phrase>
                </entry>
                <entry><phrase role="left">25 or 37°C</phrase>
                </entry>
                <entry><phrase role="left">37°C</phrase>
                </entry>
                <entry><phrase role="left">35–37°C</phrase>
                </entry>
                <entry><phrase role="left">22°C; no growth at 37°C</phrase>
                </entry>
                <entry><phrase role="left">20°C; no growth at 37°C</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Catalase</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="center">–</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Oxidase</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Acid from:</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">Glucose<superscript><emphasis><anchor id="ch0066s0000a0019"/><link linkend="ch0066s0000a0021">b</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="left">Weakly +</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Maltose</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Sucrose</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">V</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Glycerol</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Citrulline ureidase</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
                <entry><phrase role="center">NT</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">ANI (%) vs. <emphasis>F. tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">97–98</phrase>
                </entry>
                <entry><phrase role="center">82–83</phrase>
                </entry>
                <entry><phrase role="center">90</phrase>
                </entry>
                <entry><phrase role="center">87</phrase>
                </entry>
                <entry><phrase role="center">82</phrase>
                </entry>
                <entry><phrase role="center">80</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">16S identity (%) to <emphasis>F. tularensis</emphasis></phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">99</phrase>
                </entry>
                <entry><phrase role="center">&gt;99</phrase>
                </entry>
                <entry><phrase role="center">98</phrase>
                </entry>
                <entry><phrase role="center">97</phrase>
                </entry>
                <entry><phrase role="center">96</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0066s0000a0020"/><link linkend="ch0066s0000a0018">a</link></emphasis></superscript>V, variable or slow reaction; NT, not tested.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0066s0000a0021"/><link linkend="ch0066s0000a0019">b</link></emphasis></superscript>Delayed or variable reaction.</para>
        <table id="ch0066s0000t0003"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0066s0000a0022"/><link linkend="ch0066s0000a0014">TABLE 3</link></phrase></emphasis> Epidemiology of <emphasis>Francisella</emphasis> spp. affecting humans<superscript><link linkend="ch0066s0000a0024">a</link></superscript><anchor id="ch0066s0000a0023"/>
</title>
          
          <tgroup cols="4">
            <tbody>
              <row>
                <entry><phrase role="left">Species</phrase>
                </entry>
                <entry><phrase role="left">Infection sources</phrase>
                </entry>
                <entry><phrase role="left">Geographic distribution (documented cases)</phrase>
                </entry>
                <entry><phrase role="left">Disease (humans)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> (type A)</phrase>
                </entry>
                <entry><phrase role="left">Animals (primarily rabbits and cats), ticks, deerflies</phrase>
                </entry>
                <entry><phrase role="left">North America (United States and Canada)</phrase>
                </entry>
                <entry><phrase role="left">Tularemia (all forms); severe disease</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> (type B)</phrase>
                </entry>
                <entry><phrase role="left">Animals (primarily rodents), ticks (mosquitoes in Europe)</phrase>
                </entry>
                <entry><phrase role="left">Northern Hemisphere, Australia</phrase>
                </entry>
                <entry><phrase role="left">Tularemia (all forms); moderate to severe disease</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>F. novicida</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Saltwater</phrase>
                </entry>
                <entry><phrase role="left">United States, Thailand</phrase>
                </entry>
                <entry><phrase role="left">Rare; mild illness (primarily immunocompromised patients)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>F. philomiragia</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Saltwater</phrase>
                </entry>
                <entry><phrase role="left">United States, Turkey, Switzerland, Australia, France</phrase>
                </entry>
                <entry><phrase role="left">Very rare; mild illness (primarily immunocompromised patients)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>F. hispaniensis</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Saltwater</phrase>
                </entry>
                <entry><phrase role="left">Spain, Australia, China</phrase>
                </entry>
                <entry><phrase role="left">Very rare</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">
                    <emphasis>F. opportunistica</emphasis>
                  </phrase>
                </entry>
                <entry><phrase role="left">Unknown</phrase>
                </entry>
                <entry><phrase role="left">United States</phrase>
                </entry>
                <entry><phrase role="left">Very rare</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0066s0000a0024"/><link linkend="ch0066s0000a0023">a</link></emphasis></superscript> Human infections documented in the published literature.</para>
        <para id="ch0066s0000p0015">In contrast to<emphasis>F. tularensis, F. novicida</emphasis> and <emphasis>F. philomiragia</emphasis> do not appear to circulate in animal or arthropod hosts. Arthropods infected with <emphasis>F. novicida</emphasis> or <emphasis>F. philomiragia</emphasis> have never been identified. <emphasis>F. philomiragia</emphasis> has been isolated from a muskrat and from a dog (<link linkend="ch0066s0000li0043">43</link>, <link linkend="ch0066s0000li0044">44</link>). Transmission of <emphasis>F. novicida</emphasis> and <emphasis>F. philomiragia</emphasis> to humans appears to be associated with proximity to or contact with saltwater sources, such as near-drowning (<link linkend="ch0066s0000li0008">8</link>, <link linkend="ch0066s0000li0045">45</link>). One outbreak of <emphasis>F. novicida</emphasis> disease in humans has been reported. This outbreak occurred among inmates of a correctional facility and was associated with consumption of ice from outdoor ice machines (<link linkend="ch0066s0000li0046">46</link>).</para>
        <para id="ch0066s0000p0016">Most isolates of<emphasis>F. novicida</emphasis> are from North America, although one case has been reported in Thailand (<link linkend="ch0066s0000li0015">15</link>, <link linkend="ch0066s0000li0047">47</link>). Similarly, most isolates of <emphasis>F. philomiragia</emphasis> have been from North America; however, isolates have also been reported from France, Switzerland, Turkey, and Australia (<link linkend="ch0066s0000li0008">8</link>, <link linkend="ch0066s0000li0010">10</link>, <link linkend="ch0066s0000li0001">1</link><link linkend="ch0066s0000li0005">5</link>, <link linkend="ch0066s0000li0048">48</link>–<link linkend="ch0066s0000li0050">50</link>).</para>
      </sect2>
      <sect2 id="ch0066s0001s0004">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0066s0001a0005"/>
        <anchor id="ch0066s0000a0025"/>
      </sect2>
    </sect1>
    <sect1 id="ch0066s0002">
      <title>F. tularensis</title>
      <anchor id="ch0066s0002a0001"/>
      <anchor id="ch0066s0000a0026"/>
      <para id="ch0066s0000p0017">Tularemia has been known historically by several synonyms, such as rabbit fever, deerfly fever, market men’s disease, glandular type of tick fever, Ohara’s or yato-byo disease, and water rat trappers’ disease, attesting to the variety of clinical presentations, the infectious agent’s ubiquitous presence in nature, and the means by which humans may acquire the infection.</para>
      <para id="ch0066s0000p0018">The clinical spectrum of tularemia depends on the mode of transmission, the virulence of the infecting strain, the immune status of the host, and timely diagnosis and treatment (<link linkend="ch0066s0000li0051">51</link>). Tularemia can be misdiagnosed, since the disease is rare and its symptoms are not unique; a sudden onset of chills, fever, headache, and generalized malaise characterizes the onset of illness. The incubation period is typically 3 to 5 days, but it can range from 1 to 21 days (<link linkend="ch0066s0000li0051">51</link>). Disease presentation (signs and symptoms) correlates with the route of bacterial entry. All forms of tularemia are accompanied by fever, and most are also associated with lymphadenopathy (<link linkend="ch0066s0000li0051">51</link>). The most common clinical form of tularemia is ulceroglandular disease (45 to 80% of the reported cases), where the portal of entry is via an infective arthropod bite or other inoculation through the skin barrier. Glandular tularemia is similar to ulceroglandular disease but lacks the ulcerated site of infection. Oculoglandular tularemia occurs when the conjunctiva is the initial site of infection. Oropharyngeal tularemia occurs from ingestion of contaminated water or food and is characterized by pharyngeal lymphadenopathy. Pneumonic tularemia follows direct inhalation of the organism and is considered the most severe form of the disease. Typhoidal tularemia lacks localized signs, making it the most difficult form to recognize. For all forms, if untreated, bacterial dissemination from the primary site of infection can lead to secondary clinical presentations, such as sepsis or pneumonia.</para>
      <para id="ch0066s0000p0019">The severity of infection can range from mild and self-limiting to fatal and is largely dependent on the infecting strain. Little or no tularemia-related mortality is reported in Europe and Asia, where only<emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> causes tularemia (<link linkend="ch0066s0000li0030">30</link>). In comparison, estimates of mortality in the United States, where both <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> and <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> are present, range from 2 to 9% (<link linkend="ch0066s0000li0052">52</link>, <link linkend="ch0066s0000li0053">53</link>). Among culture-confirmed human cases in the United States, infections due to strains of <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> in the A1 subpopulation result in higher mortality than infections caused by <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> A2 strains or <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> (<link linkend="ch0066s0000li0032">32</link>, <link linkend="ch0066s0000li0034">34</link>).</para>
      <para id="ch0066s0000p0020">The third subspecies of<emphasis>F. tularensis, F. tularensis</emphasis> subsp. <emphasis>mediasiatica</emphasis>, has been isolated only from regions of Russia and Central Asia, and no human illness due to this subspecies has been described (<link linkend="ch0066s0000li0031">31</link>).</para>
    </sect1>
    <sect1 id="ch0066s0003">
      <title>F. novicida and F. philomiragia</title>
      <anchor id="ch0066s0003a0001"/>
      <anchor id="ch0066s0000a0027"/>
      <para id="ch0066s0000p0021">Human infections caused by<emphasis>F. novicida</emphasis> and <emphasis>F. philomiragia</emphasis> are rare, as these species primarily infect patients with underlying immune compromising conditions. Healthy individuals present with mild illness (regional lymphadenopathy). Patients with immunocompromising conditions, primarily underlying liver disease, present with fevers, with <emphasis>F. novicida</emphasis> isolated from blood samples (<link linkend="ch0066s0000li0046">46</link>). <emphasis>F. novicida</emphasis> has also been associated with near-drowning incidents (<link linkend="ch0066s0000li0045">45</link>).</para>
      <anchor id="ch0066s0000a0028"/>
      <beginpage pagenum="963"/>
      <para id="ch0066s0000p0022">Similarly, few<emphasis>F. philomiragia</emphasis> infections have been described (<link linkend="ch0066s0000li0054">54</link>). Most cases have involved either a host with an impaired physical barrier to infection (near-drowning) or an impaired immunologic defense system (most commonly chronic granulomatous disease).</para>
    </sect1>
    <sect1 id="ch0066s0004">
      <title>Other Francisella Species</title>
      <anchor id="ch0066s0004a0001"/>
      <anchor id="ch0066s0000a0029"/>
      <para id="ch0066s0000p0023">Very few human cases have been reported with other<emphasis>Francisella</emphasis> species. Most cases of <emphasis>F. hispaniensis</emphasis> infection have been associated with exposure to brackish or saltwater (<link linkend="ch0066s0000li0014">14</link>–<link linkend="ch0066s0000li0016">16</link>). The isolate from the first case was originally described as “<emphasis>novicida</emphasis>-like” but has subsequently been reclassified as <emphasis>F. hispaniensis</emphasis> (<link linkend="ch0066s0000li0009">9</link>, <link linkend="ch0066s0000li0015">15</link>). <emphasis>F. opportunistica</emphasis> was isolated from the blood or cerebrospinal fluid of three patients in the United States, all with immune compromising conditions but with no recognized common exposure (<link linkend="ch0066s0000li0017">17</link>, <link linkend="ch0066s0000li0055">55</link>). Another novel <emphasis>Francisella</emphasis> sp. was isolated in 2011 from a cutaneous lesion of a patient in the United States (<link linkend="ch0066s0000li0056">56</link>).</para>
      <sect2 id="ch0066s0004s0001">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0066s0004a0002"/>
        <anchor id="ch0066s0000a0030"/>
        <para id="ch0066s0000p0024">Clinical laboratories should be aware of the sentinel-level clinical microbiology laboratory guidelines as outlined by the American Society for Microbiology (<ulink url="https://asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C">https://asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C</ulink>). In the United States, <emphasis>F. tularensis</emphasis> is classified as a Tier 1 select agent (see <ulink url="ch0031#ch0031s0001">chapter 16</ulink> of this <emphasis>Manual</emphasis>). In the European Union and Russia, <emphasis>F. tularensis</emphasis> is classified as belonging to the very-high-threat group and group 1, respectively (<link linkend="ch0066s0000li0057">57</link>). To receive or possess <emphasis>F. tularensis</emphasis> strains in the United States, laboratories must be registered with the Federal Select Agent Program (<ulink url="http://www.selectagents.gov">http://www.selectagents.gov</ulink>). Clinical laboratories that do not store confirmed select agents are exempt from the registration requirement. Unregistered laboratories may perform testing for select agents as long as the laboratory destroys or transfers to a registered laboratory any select agent (including clinical samples the isolate was derived from) within 7 days after organism identification. <emphasis>F. novicida</emphasis> isolates (also referred to as <emphasis>F. tularensis</emphasis> subsp. <emphasis>novicida</emphasis>) are exempt from select agent regulations; see the list of excluded strains at <ulink url="https://www.selectagents.gov/sat/exclusions/hhs.htm">https://www.selectagents.gov/sat/exclusions/hhs.htm</ulink>.</para>
        <para id="ch0066s0000p0025">The choice of specimen for direct detection is generally dependent on the form of clinical illness (<link linkend="ch0066s0000li0051">51</link>). Whole blood is an acceptable specimen for all clinical forms of tularemia, although this sample lacks sensitivity in the early stages of disease progression. Bronchial and tracheal washes or aspirates, transthoracic lung aspirates, and pleural fluid (if effusions are present) are appropriate specimens for pneumonic tularemia. Swabs of visible lesions are most used for diagnosis of ulceroglandular, oculoglandular, and oropharyngeal tularemia. Aspirates from lymph nodes can be used for diagnosis of ulceroglandular, glandular, and oropharyngeal tularemia. For testing of necropsied materials from animals, appropriate samples include lymph node, lung, liver, and spleen tissues and bone marrow.</para>
        <para id="ch0066s0000p0026">For specimens to be tested by culture, it is important, where possible, to decontaminate the surface area prior to specimen collection. Contamination of the sample with normal microbiota could interfere with the interpretation of culture results. To minimize loss of viability, specimens should be delivered to the clinical laboratory promptly for testing. Freezing of samples is not recommended because of the lysis of live bacteria upon thawing, unless in a preservative environment, such as tissue specimens or glycerol-containing solutions.<emphasis>F. tularensis</emphasis> should remain viable for 7 days at ambient room temperature when stored in Amies medium (<link linkend="ch0066s0000li0058">58</link>). ESwabs (COPAN Diagnostics, Murrieta, CA) have not been specifically tested for use with <emphasis>F. tularensis</emphasis> but may be suitable for transport, as they are based on Amies medium. Modified Stuart medium and saline are inadequate for keeping <emphasis>F. tularensis</emphasis> viable during transport (<link linkend="ch0066s0000li0058">58</link>).</para>
        <para id="ch0066s0000p0027">For indirect detection, serum is a standard specimen for serologic diagnosis of all forms of illness. Separation from blood should take place as soon as possible. Frozen serum samples can often be accepted for serologic testing.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0066s0005">
      <title>Laboratory Safety Issues for Handling of F. tularensis Cultures</title>
      <anchor id="ch0066s0005a0001"/>
      <anchor id="ch0066s0000a0031"/>
      <para id="ch0066s0000p0028">Personnel handling diagnostic cultures of<emphasis>F. tularensis</emphasis> are at increased risk for infection. Due to the extremely low infectious dose for <emphasis>F. tularensis</emphasis>, tularemia has historically been one of the most reported laboratory-associated bacterial infections, primarily when safeguards such as biological safety cabinets and personal protective equipment are not used (<link linkend="ch0066s0000li0059">59</link>, <link linkend="ch0066s0000li0060">60</link>). Rare laboratory infections have been reported in recent decades (<link linkend="ch0066s0000li0061">61</link>–<link linkend="ch0066s0000li0063">63</link>). BSL-2 practices, containment equipment, and facilities are recommended for initial processing of clinical specimens where <emphasis>F. tularensis</emphasis> is suspected. BSL-3 practices, containment equipment, and facilities are recommended for all manipulations of suspect cultures, including preparatory work for identification systems (<link linkend="ch0066s0000li0064">64</link>). Due to the high concentration of organisms, manipulation of cultures presents the greatest risk to laboratory workers (<link linkend="ch0066s0000li0060">60</link>). Management options for laboratorians who have worked with <emphasis>F. tularensis</emphasis> without appropriate precautions include fever watch or antibiotic prophylaxis. Factors to consider include the nature of the exposure, incubation period, and level of concern. More guidance is available at <ulink url="https://www.cdc.gov/tularemia/laboratoryexposure/index.html">https://www.cdc.gov/tularemia/laboratoryexposure/index.html</ulink>. Laboratories should consider developing policies that encourage physicians to alert the laboratory if a diagnosis of tularemia is expected.</para>
      <sect2 id="ch0066s0005s0001">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0066s0005a0002"/>
        <anchor id="ch0066s0000a0032"/>
      </sect2>
    </sect1>
    <sect1 id="ch0066s0006">
      <title>Microscopy</title>
      <anchor id="ch0066s0006a0001"/>
      <anchor id="ch0066s0000a0033"/>
      <para id="ch0066s0000p0029">Under microscopic examination of Gram-stained specimens,<emphasis>Francisella</emphasis> cells are single, tiny, and pleomorphic. They counterstain faintly with safranin and can easily be overlooked (<anchor id="ch0066s0000a0034"/><link linkend="ch0066s0000a0037">Fig. 1</link>). <emphasis>F. tularensis</emphasis> cells are smaller than those of <emphasis>Haemophilus</emphasis> spp. Basic fuchsin counterstains <emphasis>F. tularensis</emphasis> better than safranin. Gram staining of clinical specimens is usually of limited diagnostic value. <emphasis>F. tularensis</emphasis> should be included in the clinical laboratory differential if very small, faintly staining Gram-negative coccobacilli are seen.</para>
    </sect1>
    <sect1 id="ch0066s0007">
      <title>Antigen Detection</title>
      <anchor id="ch0066s0007a0001"/>
      <anchor id="ch0066s0000a0035"/>
      <para id="ch0066s0000p0030">Immunohistochemical staining using a monoclonal antibody directed against the lipopolysaccharide has been used to visualize<emphasis>F. tularensis</emphasis> in formalin-fixed tissues (<link linkend="ch0066s0000li0065">65</link>). In the United States, direct fluorescent antibody (DFA) testing of isolates may be available in reference laboratories within the Laboratory Response Network (LRN). DFA staining involves the use of a fluorescein isothiocyanate-labeled hyperimmune rabbit polyclonal antibody directed against whole, killed <emphasis>F. tularensis</emphasis> cells. The DFA reagent does not cross-react with <emphasis>F. novicida</emphasis> or <emphasis>F. philomiragia</emphasis>.</para>
      <anchor id="ch0066s0000a0036"/>
      <beginpage pagenum="964"/>
      <figure id="ch0066s0000f0001"><title><phrase role="figureLabel"><anchor id="ch0066s0000a0037"/><link linkend="ch0066s0000a0034">Figure 1</link></phrase> Gram stain of <emphasis>F. tularensis.</emphasis> Courtesy of the CDC Public Health Image Library (Larry Stauffer, Oregon State Public Health Laboratory).</title>
        
        <mediaobject>
          <imageobject>
            <imagedata fileref="Ch0066f03.jpg" width="100%" scalefit="1"/>
          </imageobject>
        </mediaobject>
      </figure>
    </sect1>
    <sect1 id="ch0066s0008">
      <title>Nucleic Acid Detection</title>
      <anchor id="ch0066s0008a0001"/>
      <anchor id="ch0066s0000a0038"/>
      <para id="ch0066s0000p0031">Because of the relative rarity of human tularemia, evaluation of molecular diagnostics with clinical specimens has been limited. Real-time nucleic acid amplification test (NAAT) assays using 5′ hydrolysis (TaqMan) probes have been applied to detect<emphasis>F. tularensis</emphasis> DNA in clinical specimens (<link linkend="ch0066s0000li0066">66</link>–<link linkend="ch0066s0000li0070">70</link>). Real-time NAAT assays for detection of <emphasis>F. tularensis</emphasis> in blood specimens and suspect cultures are available in LRN reference laboratories in the United States. Tularemia can also be detected by sequencing methods, including either targeted (typically 16S rRNA gene) or shotgun sequencing methods (<link linkend="ch0066s0000li0071">71</link>). One test that shows promise is pathogen identification by shotgun metagenomics, which is based on untargeted next-generation sequencing (NGS), or massive parallel sequencing of the genomic content of a clinical specimen. <emphasis>F. tularensis</emphasis> has been reported to be detected by one such test performed on plasma (<link linkend="ch0066s0000li0072">72</link>). However, these methods have not been fully evaluated for <emphasis>Francisella</emphasis> species, and diagnoses should be confirmed by reference methods whenever possible.</para>
      <para id="ch0066s0000p0032">A limitation of some nucleic acid-based diagnostics for<emphasis>F. tularensis</emphasis> is the inability to discriminate <emphasis>F. tularensis</emphasis> from <emphasis>F. novicida</emphasis>, due to their high degree of genetic relatedness. Real-time NAAT assays using 5′ hydrolysis (TaqMan) probes may demonstrate cross-reaction between <emphasis>F. tularensis</emphasis> and <emphasis>F. novicida</emphasis> (<link linkend="ch0066s0000li0067">67</link>). Additionally, analysis of only the 16S rRNA gene sequence is usually insufficient to discriminate <emphasis>F. tularensis</emphasis> from <emphasis>F. novicida</emphasis> (<link linkend="ch0066s0000li0046">46</link>, <link linkend="ch0066s0000li0073">73</link>). While this may not be significant for patient management, the correct identification of species has biothreat, epidemiologic, and public health importance.</para>
      <sect2 id="ch0066s0008s0001">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0066s0008a0002"/>
        <anchor id="ch0066s0000a0039"/>
        <para id="ch0066s0000p0033"><emphasis>F. tularensis</emphasis> is slow growing and fastidious; it is auxotrophic for cysteine and as such requires an exogenous source of cysteine to grow well on artificial medium. CO<subscript>2</subscript> neither impedes nor is required for growth. <emphasis>F. tularensis</emphasis> will grow on several media common to clinical laboratories, including chocolate agar (CA) (<anchor id="ch0066s0000a0040"/><link linkend="ch0066s0000a0042">Fig. 2A</link>), buffered charcoal-yeast extract agar (BCYE), and Thayer-Martin agar. It also grows in thioglycolate broth, although growth in broth is not recommended in clinical laboratories due to the increased risk of exposure via aerosolization. A specialized medium, cystine heart agar supplemented with 9% chocolatized sheep blood (CHAB), may be used for the growth of <emphasis>F. tularensis</emphasis> in reference laboratories (<link linkend="ch0066s0000li0051">51</link>). <emphasis>F. tularensis</emphasis> grows well and displays distinctive colony morphology on CHAB, which can aid in identification (<link linkend="ch0066s0000a0042">Fig. 2B</link>). As <emphasis>F. tularensis</emphasis> grows slowly, with a 60-minute generation time, good growth is obtained by incubation for 48 hours or longer. Suspect cultures should be incubated aerobically at 35 to 37°C and observed daily for up to 14 days.</para>
        <para id="ch0066s0000p0034">When supplemented with 1 to 2% IsoVitaleX (which contains cysteine and other supplements), general bacteriological media (tryptic soy broth and Mueller-Hinton broth) can also support growth of<emphasis>F. tularensis. F. tularensis</emphasis> grows poorly or not at all on media lacking cysteine, such as sheep blood agar. Nutritionally enriched specimens, such as blood or tissue, provide an intrinsic source of cysteine that may initially permit <emphasis>F. tularensis</emphasis> growth on general bacteriological media. Upon subculture, viability of <emphasis>F. tularensis</emphasis> is lost as exogenous compounds are depleted, unless subculture is propagated on cysteine-supplemented medium.</para>
        <para id="ch0066s0000p0035">Clinical samples from normally sterile sites can be plated on nonselective agars that support growth of<emphasis>F. tularensis.</emphasis> Care should be taken not to permit laboratory contamination of <emphasis>F. tularensis</emphasis> isolates, as some environmental bacteria rapidly outcompete and inhibit the growth of <emphasis>F. tularensis</emphasis> on nonselective media (<link linkend="ch0066s0000li0074">74</link>). Clinical specimens obtained from nonsterile sites or autopsy and environmental sources should be plated on antibiotic-containing media. Incorporation of an antibiotic supplement (7.5 mg/liter of colistin, 2.5 mg/liter of amphotericin, 0.5 mg/liter of lincomycin, 4.0 mg/liter of trimethoprim, and 10 mg/liter of ampicillin) into the medium prevents other organisms from overwhelming <emphasis>F. tularensis</emphasis> (<link linkend="ch0066s0000li0074">74</link>). Commercially available antibiotic-containing media that support growth of <emphasis>F. tularensis</emphasis> include improved Thayer-Martin agar and BCYE selective agar containing polymyxin B, anisomycin, and vancomycin.</para>
        <para id="ch0066s0000p0036">Specimens for culture should be taken based on clinical presentation and before administration of antibiotics. Fresh clinical material that is likely to contain high concentrations of<emphasis>F. tularensis</emphasis> organisms, such as ulcer and wound specimens and reticuloendothelial tissue (liver, spleen, or affected lymph node tissue), is inoculated directly onto an agar plate using a sample-laden swab or loop. Larger inocula are necessary for the recovery of <emphasis>F. tularensis</emphasis> from specimens that contain a lower concentration of the organisms, such as blood, pharyngeal washes, bronchial wash fluids, and pleural fluids. Whole blood should be directly inoculated into aerobic blood culture bottles and incubated on continuous monitoring systems (<link linkend="ch0066s0000li0051">51</link>), with subsequent culture of blood culture-positive specimens on agar. Blood culture bottles should be incubated for 5 to 7 days to allow growth of <emphasis>F. tularensis.</emphasis> In a review of 30 cases of <emphasis>F. tularensis</emphasis> bacteremia, <emphasis role="strong">~</emphasis>50% of the isolations utilized the BACTEC system (<link linkend="ch0066s0000li0075">75</link>).</para>
        <anchor id="ch0066s0000a0041"/>
        <beginpage pagenum="965"/>
        <figure id="ch0066s0000f0002"><title><phrase role="figureLabel"><anchor id="ch0066s0000a0042"/><link linkend="ch0066s0000a0040">Figure 2</link></phrase> <emphasis>F. tularensis</emphasis> on CA <emphasis role="strong">(A)</emphasis> and cystine heart agar supplemented with 9% chocolatized sheep blood (CHAB) <emphasis role="strong">(B)</emphasis> after 72 and 48 hours of growth, respectively. (Panel A is courtesy of the CDC Public Health Image Library [Larry Stauffer, Oregon State Public Health Laboratory].)</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0066f02.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0066s0000p0037"><emphasis>F. novicida, F. philomiragia</emphasis>, and <emphasis>F. hispaniensis</emphasis> grow faster than <emphasis>F. tularensis</emphasis> and are less fastidious. Cysteine supplementation enhances but is not required for growth (<link linkend="ch0066s0000li0003">3</link>, <link linkend="ch0066s0000li0014">14</link>).</para>
      </sect2>
      <sect2 id="ch0066s0008s0002">
        <title>IDENTIFICATION</title>
        <anchor id="ch0066s0008a0003"/>
        <anchor id="ch0066s0000a0043"/>
        <para id="ch0066s0000p0038">Because of the rarity as well as the sporadic nature of most tularemia cases, the organism is often not suspected and is therefore not easily identified when it is cultured. The isolation of a very tiny, poorly counterstaining, slow-growing Gram-negative coccobacillus (<link linkend="ch0066s0000a0037">Fig. 1</link>) that produces 1- to 2-mm, gray or gray-white colonies on CA after 48 hours, scant to no growth on blood agar, and no growth on MacConkey agar should raise suspicion of <emphasis>F. tularensis.</emphasis> All testing on isolates suspected as being <emphasis>F. tularensis</emphasis> should be performed at a minimum within a biosafety cabinet until <emphasis>F. tularensis</emphasis> is ruled out. <emphasis>F. tularensis</emphasis> is oxidase negative, weakly catalase positive, β-lactamase positive, X and V or satellite growth negative, and urease negative. <link linkend="ch0066s0000a0005">Table 1</link> lists characteristics that can help differentiate <emphasis>F. tularensis</emphasis> from other similar Gram-negative organisms. One of the most common misidentifications of <emphasis>F. tularensis</emphasis> in culture is <emphasis>Haemophilus influenzae</emphasis>, which can be differentiated from <emphasis>F. tularensis</emphasis> based on XV or satellite tests. If <emphasis>F. tularensis</emphasis> is suspected based on these results, the isolate should be sent to a reference laboratory that can confirm (or rule out) its identification as <emphasis>F. tularensis.</emphasis> In the United States, all states have at least one LRN reference laboratory that can confirm the identification of bacterial select agents, including <emphasis>F. tularensis.</emphasis> More information is available at <ulink url="http://www.emergency.cdc.gov/lrn">http://www.emergency.cdc.gov/lrn</ulink>.</para>
        <para id="ch0066s0000p0039">On CA, BCYE, and Thayer-Martin agar after 48 h at 37°C,<emphasis>F. tularensis</emphasis> colonies are <emphasis role="strong">~</emphasis>1 mm, white to gray in color, and smooth and opaque with an entire margin (<link linkend="ch0066s0000a0042">Fig. 2A</link>). The colony morphology of <emphasis>F. tularensis</emphasis> is most distinctive when grown on CHAB; after 48 h at 37°C, <emphasis>F. tularensis</emphasis> colonies are 1 to 2 mm, raised, shiny, green, and opalescent (<link linkend="ch0066s0000a0042">Fig. 2B</link>). <emphasis>F. novicida</emphasis> and <emphasis>F. philomiragia</emphasis> grow more robustly than <emphasis>F. tularensis</emphasis> (<link linkend="ch0066s0000a0017">Table 2</link>), and colonies of <emphasis>F. philomiragia</emphasis> are mucoid.</para>
        <para id="ch0066s0000p0040">Isolates can be identified as<emphasis>F. tularensis</emphasis> using antigen or molecular detection methods, including DFA detection, NAAT, or sequencing. DFA can differentiate <emphasis>F. novicida</emphasis> from <emphasis>F. tularensis.</emphasis> Polyclonal antibodies to whole killed <emphasis>F. tularensis</emphasis> cells used in this test react poorly or not at all with <emphasis>F. novicida</emphasis> due to differences in the O antigens of the lipopolysaccharides of the two organisms (<link linkend="ch0066s0000li0051">51</link>, <link linkend="ch0066s0000li0076">76</link>).</para>
        <para id="ch0066s0000p0041">NAAT methods can also be used for identification of suspect cultures (<link linkend="ch0066s0000li0067">67</link>, <link linkend="ch0066s0000li0073">73</link>, <link linkend="ch0066s0000li0077">77</link>). A NAAT-based system has been cleared by the FDA for detection of biothreat agents including <emphasis>F. tularensis</emphasis> (<ulink url="https://www.biofiredefense.com/products/biofire-filmarray-biosurveillance-system/#Warrior">https://www.biofiredefense.com/products/biofire-filmarray-biosurveillance-system/#Warrior</ulink>). However, this system is not commercially available. As mentioned above, some <emphasis>F. tularensis</emphasis> NAAT assays cross-react with <emphasis>F. novicida.</emphasis> Therefore, it may be important to rule out <emphasis>F. novicida</emphasis> or other <emphasis>Francisella</emphasis> species as the cause of infection, particularly in areas where tularemia has not been previously reported. 16S rRNA gene sequencing can provide a genus-level identification; isolates identified by this method should be considered <emphasis>Francisella</emphasis> species and referred to an LRN reference laboratory for <emphasis>F. tularensis</emphasis>-specific testing.</para>
        <para id="ch0066s0000p0042">Commercial biochemical identification systems are not recommended for the diagnosis of<emphasis>F. tularensis</emphasis> because of the possibility of misidentification and the potential for generating infectious aerosols (<link linkend="ch0066s0000li0051">51</link>). <emphasis>F. tularensis</emphasis> may be misidentified as <emphasis>H. influenzae</emphasis> or <emphasis>Aggregatibacter</emphasis> (see ASM sentinel-level clinical laboratory guidelines at <ulink url="https://asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C">https://asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C</ulink>). Misidentification is largely due to a lack of biochemical reactivity by <emphasis>F. tularensis</emphasis>, slow growth, and the limited number of strains used in the development of databases. Misidentification of both <emphasis>F. novicida</emphasis> and <emphasis>F. hispaniensis</emphasis> as <emphasis>F. tularensis</emphasis> using these systems in clinical laboratory settings has been described (<link linkend="ch0066s0000li0014">14</link>, <link linkend="ch0066s0000li0045">45</link>). Other organisms, such as <emphasis>Veillonella, Pseudomonas</emphasis>, and <emphasis>Paenibacillus</emphasis> spp., have also been misidentified as <emphasis>F. tularensis</emphasis> by these systems, leading to unnecessary biosafety and biosecurity concerns (<link linkend="ch0066s0000li0078">78</link>–<link linkend="ch0066s0000li0080">80</link>).</para>
        <para id="ch0066s0000p0043">Matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry (MS) has been used for identification and differentiation of<emphasis>Francisella</emphasis> strains in research and reference laboratories (<link linkend="ch0066s0000li0081">81</link>–<link linkend="ch0066s0000li0085">85</link>). However, as with biochemical systems, <emphasis>Francisella</emphasis> species may not be present in available commercial databases, and use of commercial MALDI-TOF MS systems is likely to result in no reliable identification in the clinical laboratory (<link linkend="ch0066s0000li0083">83</link>). A MALDI-TOF MS database containing <emphasis>F. tularensis</emphasis> for <emphasis>in vitro</emphasis> diagnostic use is available with special security clearance for use with the Bruker Biotyper instrument, but this database still requires in-house supplementation to attain species-level identifications (<link linkend="ch0066s0000li0082">82</link>, <link linkend="ch0066s0000li0086">86</link>). For the bioMérieux VITEK MS system, <emphasis>F. tularensis</emphasis> is available only in the database labeled for research use only (<link linkend="ch0066s0000li0083">83</link>). Thus, this method is currently of limited utility in clinical laboratories. Safety considerations in target preparation for MALDI-TOF MS analysis, including preparation in a biosafety cabinet, must also be considered. An ethanol-formic acid tube extraction procedure inactivates <emphasis>F. tularensis</emphasis> and other select agents more reliably than direct colony or on-plate formic acid extraction (<link linkend="ch0066s0000li0083">83</link>, <link linkend="ch0066s0000li0087">87</link>).</para>
        <para id="ch0066s0000p0044">Potential indications of misidentification by automated systems (biochemical, MALDI-TOF MS) include a low probability or confidence value and/or an identification of a pathogen inconsistent with the clinical or microbiological picture. Results from automated identification systems should be analyzed critically in the clinical laboratory, taking into consideration the reliability of these systems for accurate identification of select agents, slow-growing, and/or rare organisms along with Gram stain characteristics, colony morphology, rate of growth, and culture conditions. A high level of suspicion by clinical microbiologists is essential for accurate and timely diagnosis of tularemia and to prevent laboratory-acquired infections.</para>
      </sect2>
      <sect2 id="ch0066s0008s0003">
        <title>TYPING SYSTEMS</title>
        <anchor id="ch0066s0008a0004"/>
        <anchor id="ch0066s0000a0044"/>
        <para id="ch0066s0000p0045">Once an isolate has been identified as a<emphasis>Francisella</emphasis> sp., supplemental tests can be used for additional characterization, including typing of species, subspecies, and strain. Glycerol fermentation and citrulline ureidase activity distinguish <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> from <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> (<link linkend="ch0066s0000a0017">Table 2</link>). Molecular methods including PCR and sequencing can type isolates at the levels of genus, species, subspecies (<emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> or <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis>), and subclade (e.g., <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> subclades A1 and A2) (<link linkend="ch0066s0000li0051">51</link>, <link linkend="ch0066s0000li0088">88</link>, <link linkend="ch0066s0000li0089">89</link>). Whole-genome sequence-based typing shows improved resolution and is likely to be used more extensively in the future as next-generation sequencing technology becomes more readily available (<link linkend="ch0066s0000li0090">90</link>).</para>
        <anchor id="ch0066s0000a0045"/>
        <beginpage pagenum="966"/>
      </sect2>
      <sect2 id="ch0066s0008s0004">
        <title>SEROLOGIC TESTS</title>
        <anchor id="ch0066s0008a0005"/>
        <anchor id="ch0066s0000a0046"/>
        <para id="ch0066s0000p0046">A confirmatory diagnosis of tularemia can be established serologically by demonstrating a 4-fold change between titers of specific antibody to<emphasis>F. tularensis</emphasis> antigen in acute- and convalescent-phase sera (<link linkend="ch0066s0000li0051">51</link>). Serological assays do not distinguish between <emphasis>F. tularensis</emphasis> subsp. <emphasis>tularensis</emphasis> and <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica.</emphasis> A single positive antibody titer is a presumptive diagnosis of tularemia. As antibody responses to <emphasis>F. tularensis</emphasis> generally require 10 to 20 days to develop postinfection, serologic testing is of limited use in clinical management of patients with acute illness. Immunoglobulin M (IgM), IgA, and IgG antibodies may appear simultaneously. Antibodies to <emphasis>F. tularensis</emphasis> can persist for more than 10 years, including IgM responses, which are therefore not indicative of early or recent infection (<link linkend="ch0066s0000li0091">91</link>).</para>
        <para id="ch0066s0000p0047">Agglutination testing, by either the tube agglutination or the microagglutination method, is a standard serological test for determining the presence of antibodies in tularemia (<link linkend="ch0066s0000li0051">51</link>, <link linkend="ch0066s0000li0091">91</link>). Formalin-killed antigen is commercially available and is also prepared within reference laboratories worldwide. A single specimen with a tube agglutination titer of ≥1:160 or a microagglutination titer of ≥1:128 is considered positive. Formalin-killed <emphasis>F. tularensis</emphasis> whole-cell antigen may display low-level cross-reactivity with <emphasis>Brucella</emphasis> antibodies. False-positive results due to antigenic cross-reaction are more common at titers <emphasis role="underline">&lt;</emphasis>1:40 (<link linkend="ch0066s0000li0092">92</link>). No cross-reactivity of <emphasis>F. novicida</emphasis> or <emphasis>F. philomiragia</emphasis> sera with killed <emphasis>F. tularensis</emphasis> cells has been observed (<link linkend="ch0066s0000li0091">91</link>).</para>
        <para id="ch0066s0000p0048">Enzyme-linked immunosorbent assays (ELISAs) can also be used for serological diagnosis of tularemia (<link linkend="ch0066s0000li0091">91</link>). The lipopolysaccharide and/or outer membrane fraction is the primary ELISA antigen used in test applications. Antibody responses are usually detected earlier by ELISA compared to agglutination tests. The higher sensitivity of anti-<emphasis>F. tularensis</emphasis> ELISAs, however, can result in lower specificity as compared to microagglutination (cutoff, <emphasis role="underline">&gt;</emphasis>1:80) (<link linkend="ch0066s0000li0093">93</link>).</para>
      </sect2>
      <sect2 id="ch0066s0008s0005">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0066s0008a0006"/>
        <anchor id="ch0066s0000a0047"/>
        <para id="ch0066s0000p0049"><emphasis>F. tularensis</emphasis> infections are treatable with antibiotics. Antibiotics used to treat tularemia include streptomycin, gentamicin, doxycycline, and ciprofloxacin. For more information see <ulink url="https://www.cdc.gov/tularemia/clinicians/index.html">https://www.cdc.gov/tularemia/clinicians/index.html</ulink>. All naturally occurring isolates of <emphasis>F. tularensis</emphasis> to date have been susceptible to aminoglycosides, tetracyclines, and fluoroquinolones (<link linkend="ch0066s0000li0051">51</link>, <link linkend="ch0066s0000li0094">94</link>). The risk for development of antibiotic resistance in clinical disease is low, as tularemia is an end-stage disease and is not transmitted from person to person (<link linkend="ch0066s0000li0051">51</link>). Treatment failures in tularemia patients correlate with a delay in the initiation of antibiotics, rather than development of resistance (<link linkend="ch0066s0000li0066">66</link>, <link linkend="ch0066s0000li0095">95</link>). Lymph node suppuration, which is nonresponsive to all classes of antibiotics, can develop in these cases, and recovery times can be greater than 70 days (<link linkend="ch0066s0000li0095">95</link>).</para>
        <para id="ch0066s0000p0050">β-Lactam antibiotics are not used for treatment of tularemia, as<emphasis>F. tularensis</emphasis> strains produce a class A β-lactamase, FTU-1 (<link linkend="ch0066s0000li0096">96</link>). β-Lactam resistance in <emphasis>F. tularensis</emphasis> appears to be limited to penicillins; <emphasis>in vitro</emphasis> MIC determinations indicate that FTU-1 does not confer resistance to other β-lactams, including first- and second-generation cephalosporins (<link linkend="ch0066s0000li0096">96</link>). Although third-generation cephalosporins have been shown to be active against <emphasis>F. tularensis in vitro</emphasis>, clinical experience indicates that ceftriaxone is not effective for treatment of tularemia (<link linkend="ch0066s0000li0097">97</link>). <emphasis>F. tularensis</emphasis> subsp. <emphasis>holarctica</emphasis> strains from Central and Eastern Europe and Asia are naturally resistant to erythromycin and other macrolides (<link linkend="ch0066s0000li0098">98</link>).</para>
        <para id="ch0066s0000p0051">Antimicrobial susceptibility testing of<emphasis>F. tularensis</emphasis> is not performed in clinical microbiology laboratories because of safety concerns and because resistance to antibiotics used for clinical treatment of tularemia has never been reported (<link linkend="ch0066s0000li0094">94</link>). The Clinical and Laboratory Standards Institute (CLSI) has published interpretative criteria and quality control limits for broth microdilution of <emphasis>F. tularensis</emphasis> using cation-adjusted Mueller-Hinton medium supplemented with 2% defined growth supplement (<link linkend="ch0066s0000li0099">99</link>).</para>
      </sect2>
      <sect2 id="ch0066s0008s0006">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0066s0008a0007"/>
        <anchor id="ch0066s0000a0048"/>
        <para id="ch0066s0000p0052">Isolation of a very tiny Gram-negative bacterium that grows slowly, shows fastidious growth characteristics, and is oxidase negative, weakly catalase positive, urease negative, X (hemin)/V (NAD) or satellite negative, and β-lactamase positive should be strongly suspected as<emphasis>F. tularensis</emphasis> and referred to a reference laboratory (LRN reference laboratories in the United States) (<link linkend="ch0066s0000li0051">51</link>). Confirmation of <emphasis>F. tularensis</emphasis> infections includes (i) recovery of an isolate and identification as <emphasis>F. tularensis</emphasis> and/or (ii) a 4-fold difference in titers in acute- and convalescent-phase serum samples, with one of the paired samples having a positive titer. A positive test result for a primary clinical specimen using antigen or molecular detection methods, including DFA staining, immunohistochemical staining, or NAAT, provides only a presumptive diagnosis of <emphasis>F. tularensis.</emphasis> A single positive serum sample is also considered presumptive for tularemia. Culture provides a conclusive diagnosis of infection and should be attempted using appropriate biosafety measures. Serology is commonly used for laboratory confirmation of <emphasis>F. tularensis</emphasis> infection, due to the organism’s slow growth and fastidious nature. Patients’ symptoms must be taken into account to ensure that a laboratory diagnosis of tularemia is compatible with the clinical picture. Any <emphasis>Francisella</emphasis> sp. identification by nucleic acid detection (PCR, shotgun metagenomics, 16S rRNA gene sequencing) or automated systems (e.g., MALDI-TOF MS, biochemical systems) should be referred to reference laboratories (LRN reference laboratories in the United States) for <emphasis>F. tularensis</emphasis>-specific testing.</para>
        <para id="ch0066s0000p0053">In the United States, tularemia is a nationally notifiable disease and<emphasis>F. tularensis</emphasis> is classified as a Tier 1 select agent. Identification of a bacterial select agent requires isolation of the organism in culture and confirmatory testing. Laboratories identifying an organism as <emphasis>F. tularensis</emphasis> are required to report this finding to the Select Agent Program within 24 hours and submit a Form 4 within 7 calendar days. Report forms, contact information, laboratory registration information, and pertinent citations of the U.S. Federal Code may be found at <ulink url="http://www.selectagents.gov">http://www.selectagents.gov</ulink>. <emphasis>F. tularensis</emphasis> is also a notifiable disease in most European countries, and information is collected by the European Centre for Disease Prevention and Control (<link linkend="ch0066s0000li0030">30</link>, <link linkend="ch0066s0000li0036">36</link>).</para>
        <para id="ch0066s0000p0054">Other<emphasis>Francisella</emphasis> species, particularly <emphasis>F. novicida</emphasis>, may be confused with <emphasis>F. tularensis</emphasis> in laboratory testing. Diagnosis of these organisms is challenging due to their rarity and their similarity to <emphasis>F. tularensis.</emphasis> Clinical laboratories are encouraged to consult reference laboratories if a <emphasis>Francisella</emphasis> species is suspected.</para>
        <anchor id="ch0066s0000a0049"/>
        <beginpage pagenum="967"/>
        <para id="ch0066s0000p0055"><emphasis>The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention</emphasis>.</para>
      </sect2>
      <sect2 id="ch0066s0008s0007">
        <title>REFERENCES</title>
        <anchor id="ch0066s0008a0008"/>
        <anchor id="ch0066s0000a0050"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0066s0000li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Qu P-H, Li Y, Salam N, Chen S-Y, Liu L, Gu Q, Fang B-Z, Xiao M, Li M, Chen C, Li W-J.</emphasis> 2016. <citetitle><emphasis>Allofrancisella inopinata</emphasis></citetitle> gen. nov., sp. nov. and <citetitle><emphasis>Allofrancisella frigidaquae</emphasis></citetitle> sp. nov., isolated from water-cooling systems, and transfer of <citetitle><emphasis>Francisella guangzhouensis</emphasis></citetitle> Qu et al. 2013 to the new genus as <citetitle><emphasis>Allofrancisella guangzhouensis</emphasis></citetitle> comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>4832–4838.</para>
          </listitem>
          <listitem id="ch0066s0000li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Zheng ML, Jiao JY, Dong L, Han MX, Li LH, Xiao M, Chen C, Qu PH, Li WJ.</emphasis> 2019. <citetitle><emphasis>Pseudofrancisella aestuarii</emphasis></citetitle> gen. nov., sp. nov., a novel member of the family <citetitle><emphasis>Francisellaceae</emphasis></citetitle> isolated from estuarine seawater. <citetitle><emphasis>Antonie van Leeuwenhoek</emphasis></citetitle> <emphasis role="strong">112:</emphasis>877–886.</para>
          </listitem>
          <listitem id="ch0066s0000li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Sjöstedt A.</emphasis> 2005. <citetitle><emphasis>Francisella</emphasis></citetitle>, p 200–210. <citetitle><emphasis>In</emphasis></citetitle> Brenner DJ, Krieg NR, Staley JT, Garrity GM (ed), <citetitle><emphasis>Bergey’s Manual of Systematic Bacteriology</emphasis></citetitle>, 2nd ed. Springer-Verlag, New York, NY.</para>
          </listitem>
          <listitem id="ch0066s0000li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Sjöstedt A.</emphasis> 2007. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. <citetitle><emphasis>Ann N Y Acad Sci</emphasis></citetitle> <emphasis role="strong">1105:</emphasis>1–29.</para>
          </listitem>
          <listitem id="ch0066s0000li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Sjödin A, Svensson K, Öhrman C, Ahlinder J, Lindgren P, Duodu S, Johansson A, Colquhoun DJ, Larsson P, Forsman M.</emphasis> 2012. Genome characterisation of the genus <citetitle><emphasis>Francisella</emphasis></citetitle> reveals insight into similar evolutionary paths in pathogens of mammals and fish. <citetitle><emphasis>BMC Genomics</emphasis></citetitle> <emphasis role="strong">13:</emphasis>268.</para>
          </listitem>
          <listitem id="ch0066s0000li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Larsson P, Elfsmark D, Svensson K, Wikström P, Forsman M, Brettin T, Keim P, Johansson A.</emphasis> 2009. Molecular evolutionary consequences of niche restriction in <citetitle><emphasis>Francisella tularensis</emphasis></citetitle>, a facultative intracellular pathogen. <citetitle><emphasis>PLoS Pathog</emphasis></citetitle> <emphasis role="strong">5</emphasis><emphasis role="strong">:</emphasis>e1000472.</para>
          </listitem>
          <listitem id="ch0066s0000li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Kingry LC, Petersen JM.</emphasis> 2014. Comparative review of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> and <citetitle><emphasis>Francisella novicida. Front Cell Infect Microbiol</emphasis></citetitle> <emphasis role="strong">4:</emphasis>35.</para>
          </listitem>
          <listitem id="ch0066s0000li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Wenger JD, Hollis DG, Weaver RE, Baker CN, Brown GR, Brenner DJ, Broome CV.</emphasis> 1989. Infection caused by <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> (formerly <citetitle><emphasis>Yersinia philomiragia</emphasis></citetitle>). A newly recognized human pathogen. <citetitle><emphasis>Ann Intern Med</emphasis></citetitle> <emphasis role="strong">110:</emphasis>888–892.</para>
          </listitem>
          <listitem id="ch0066s0000li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Challacombe JF, Petersen JM, Gallegos-Graves V, Hodge D, Pillai S, Kuske CR.</emphasis> 2017. Whole-genome relationships among <citetitle><emphasis>Francisella</emphasis></citetitle> bacteria of diverse origins define new species and provide specific regions for detection. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">83:</emphasis>e02589–e16.</para>
          </listitem>
          <listitem id="ch0066s0000li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Hollis DG, Weaver RE, Steigerwalt AG, Wenger JD, Moss CW, Brenner DJ.</emphasis> 1989. <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> comb. nov. (<citetitle><emphasis>formerly Yersinia philomiragia</emphasis></citetitle>) and <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> biogroup <citetitle><emphasis>novicida</emphasis></citetitle> (formerly <citetitle><emphasis>Francisella novicida</emphasis></citetitle>) associated with human disease. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">27:</emphasis>1601–1608.</para>
          </listitem>
          <listitem id="ch0066s0000li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Huber B, Escudero R, Busse HJ, Seibold E, Scholz HC, Anda P, Kämpfer P, Splettstoesser WD.</emphasis> 2010. Description of <citetitle><emphasis>Francisella hispaniensis</emphasis></citetitle> sp. nov., isolated from human blood, reclassification of <citetitle><emphasis>Francisella novicida</emphasis></citetitle> (Larson et al. 1955) Olsufiev et al. 1959 as <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> subsp. <citetitle><emphasis>novicida</emphasis></citetitle> comb. nov. and emended description of the genus <citetitle><emphasis>Francisella. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1887–1896.</para>
          </listitem>
          <listitem id="ch0066s0000li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Johansson A, Celli J, Conlan W, Elkins KL, Forsman M, Keim PS, Larsson P, Manoil C, Nano FE, Petersen JM, Sjöstedt A.</emphasis> 2010. Objections to the transfer of <citetitle><emphasis>Francisella novicida</emphasis></citetitle> to the subspecies rank of <citetitle><emphasis>Francisella tularensis. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1717–1718, author reply 1718–1720.</para>
          </listitem>
          <listitem id="ch0066s0000li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Escudero R, Elía M, Sáez-Nieto JA, Menéndez V, Toledo A, Royo G, Rodríguez-Vargas M, Whipp MJ, Gil H, Jado I, Anda P.</emphasis> 2010. A possible novel <citetitle><emphasis>Francisella</emphasis></citetitle> genomic species isolated from blood and urine of a patient with severe illness. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">16:</emphasis>1026–1030.</para>
          </listitem>
          <listitem id="ch0066s0000li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Aravena-Román M, Merritt A, Inglis TJ.</emphasis> 2015. First case of <citetitle><emphasis>Francisella</emphasis></citetitle> bacteraemia in Western Australia. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">8:</emphasis>75–77.</para>
          </listitem>
          <listitem id="ch0066s0000li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Whipp MJ, Davis JM, Lum G,</emphasis> de <emphasis role="strong">Boer J, Zhou Y, Bearden SW, Petersen JM, Chu MC, Hogg G.</emphasis> 2003. Characterization of a <citetitle><emphasis>novicida</emphasis></citetitle>-like subspecies of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> isolated in Australia. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>839–842.</para>
          </listitem>
          <listitem id="ch0066s0000li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Zhou H, Yang Q, Shen L, Yao Y, Xu J, Ye J, Wu X, Yu Y, Li Z, Zhou J, Yang S.</emphasis> 2020. Seawater-associated highly pathogenic <citetitle><emphasis>Francisella hispaniensis</emphasis></citetitle> infections causing multiple organ failure. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">26:</emphasis>2424–2428.</para>
          </listitem>
          <listitem id="ch0066s0000li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Dietrich EA, Kingry LC, Kugeler KJ, Levy C, Yaglom H, Young JW, Mead PS, Petersen JM.</emphasis> 2020. <citetitle><emphasis>Francisella opportunistica</emphasis></citetitle> sp. nov., isolated from human blood and cerebrospinal fluid. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>1145–1151.</para>
          </listitem>
          <listitem id="ch0066s0000li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Mikalsen J, Olsen AB, Tengs T, Colquhoun DJ.</emphasis> 2007. <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> subsp. <citetitle><emphasis>noatunensis</emphasis></citetitle> subsp. nov., isolated from farmed Atlantic cod (<citetitle><emphasis>Gadus morhua</emphasis></citetitle> L.). <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>1960–1965.</para>
          </listitem>
          <listitem id="ch0066s0000li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Brevik ØJ, Ottem KF, Kamaishi T, Watanabe K, Nylund A.</emphasis> 2011. <citetitle><emphasis>Francisella halioticida</emphasis></citetitle> sp. nov., a pathogen of farmed giant abalone (<citetitle><emphasis>Haliotis gigantea</emphasis></citetitle>) in Japan. <citetitle><emphasis>J Appl Microbiol</emphasis></citetitle> <emphasis role="strong">111:</emphasis>1044–1056.</para>
          </listitem>
          <listitem id="ch0066s0000li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Ramirez-Paredes JG, Larsson P, Thompson KD, Penman DJ, Busse HJ, Öhrman C, Sjödin A, Soto E, Richards RH, Adams A, Colquhoun DJ.</emphasis> 2020. Reclassification of <citetitle><emphasis>Francisella noatunensis</emphasis></citetitle> subsp. <citetitle><emphasis>orientalis</emphasis></citetitle> Ottem <citetitle><emphasis>et al.</emphasis></citetitle> 2009 as <citetitle><emphasis>Francisella orientalis</emphasis></citetitle> sp. nov., <citetitle><emphasis>Francisella noatunensis</emphasis></citetitle> subsp. <citetitle><emphasis>chilensis</emphasis></citetitle> subsp. nov. and emended description of <citetitle><emphasis>Francisella noatunensis. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>2034–2048.</para>
          </listitem>
          <listitem id="ch0066s0000li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Li LH, Luo HM, Feng JH, Ming YZ, Zheng ML, Deng GY, Chen C, Li WJ, Xiao M, Qu PH.</emphasis> 2020. <citetitle><emphasis>Francisella salimarina</emphasis></citetitle> sp. nov., isolated from coastal seawater. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>3264–3272.</para>
          </listitem>
          <listitem id="ch0066s0000li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Larson MA, Nalbantoglu U, Sayood K, Zentz EB, Cer RZ, Iwen PC, Francesconi SC, Bishop-Lilly KA, Mokashi VP, Sjöstedt A, Hinrichs SH.</emphasis> 2016. Reclassification of <citetitle><emphasis>Wolbachia persica</emphasis></citetitle> as <citetitle><emphasis>Francisella persica</emphasis></citetitle> comb. nov. and emended description of the family <citetitle><emphasis>Francisellaceae. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>1200–1205.</para>
          </listitem>
          <listitem id="ch0066s0000li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Keim P, Johansson A, Wagner DM.</emphasis> 2007. Molecular epidemiology, evolution, and ecology of <citetitle><emphasis>Francisella. Ann N Y Acad Sci</emphasis></citetitle> <emphasis role="strong">1105:</emphasis>30–66.</para>
          </listitem>
          <listitem id="ch0066s0000li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Propst CN, Pylypko SL, Blower RJ, Ahmad S, Mansoor M, van Hoek ML.</emphasis> 2016. <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> infection and lethality in mammalian tissue culture cell models, <citetitle><emphasis>Galleria mellonella</emphasis></citetitle>, and BALB/c mice. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">7:</emphasis>696.</para>
          </listitem>
          <listitem id="ch0066s0000li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Olsufiev NG, Emelyanova OS, Dunayeva TN.</emphasis> 1959. Comparative study of strains of <citetitle><emphasis>B. tularense</emphasis></citetitle> in the old and new world and their taxonomy. <citetitle><emphasis>J Hyg Epidemiol Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">3:</emphasis>138–149.</para>
          </listitem>
          <listitem id="ch0066s0000li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Bröms JE, Sjöstedt A, Lavander M.</emphasis> 2010. The role of the <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> pathogenicity island in Type VI secretion, intracellular survival, and modulation of host cell signaling. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">1:</emphasis>136.</para>
          </listitem>
          <listitem id="ch0066s0000li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW, Darcy C, Sintchenko V.</emphasis> 2012. <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> subspecies <citetitle><emphasis>holarctica</emphasis></citetitle>, Tasmania, Australia, 2011. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">18:</emphasis>1484–1486.</para>
          </listitem>
          <listitem id="ch0066s0000li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Eden JS, Rose K, Ng J, Shi M, Wang Q, Sintchenko V, Holmes EC.</emphasis> 2017. <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> ssp. <citetitle><emphasis>holarctica</emphasis></citetitle> in Ringtail Possums, Australia. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">23:</emphasis>1198–1201.</para>
          </listitem>
          <listitem id="ch0066s0000li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Carvalho CL, Lopes de Carvalho I, Zé-Zé L, Núncio MS, Duarte EL.</emphasis> 2014. Tularaemia: a challenging zoonosis. <citetitle><emphasis>Comp Immunol Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">37:</emphasis>85–96.</para>
          </listitem>
          <listitem id="ch0066s0000li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Maurin M, Gyuranecz M.</emphasis> 2016. Tularaemia: clinical aspects in Europe. <citetitle><emphasis>Lancet Infect Dis</emphasis></citetitle> <emphasis role="strong">16:</emphasis>113–124.</para>
          </listitem>
          <listitem id="ch0066s0000li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Timofeev V, Bakhteeva I, Titareva G, Kopylov P, Christiany D, Mokrievich A, Dyatlov I, Vergnaud G.</emphasis> 2017. Russian isolates enlarge the known geographic diversity of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> subsp. <citetitle><emphasis>mediasiatica. PLoS One</emphasis></citetitle> <emphasis role="strong">12</emphasis><emphasis role="strong">:</emphasis>e0183714.</para>
          </listitem>
          <listitem id="ch0066s0000li0032" role="bibliographyEntry">
            <anchor id="ch0066s0000a0051"/>
            <para>32.<emphasis role="strong">Kugeler KJ, Mead PS, Janusz AM, Staples JE, Kubota KA, Chalcraft LG, Petersen JM.</emphasis> 2009. Molecular epidemiology of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> in the United States. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">48:</emphasis>863–870.</para>
          </listitem>
          <listitem id="ch0066s0000li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Petersen JM, Molins CR.</emphasis> 2010. Subpopulations of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> ssp. <citetitle><emphasis>tularensis</emphasis></citetitle> and <citetitle><emphasis>holarctica</emphasis></citetitle>: identification and associated epidemiology. <citetitle><emphasis>Future Microbiol</emphasis></citetitle> <emphasis role="strong">5:</emphasis>649–661.</para>
          </listitem>
          <listitem id="ch0066s0000li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Birdsell DN, Johansson A, Öhrman C, Kaufman E, Molins C, Pearson T, Gyuranecz M, Naumann A, Vogler AJ, Myrtennäs K, Larsson P, Forsman M, Sjödin A, Gillece JD, Schupp J, Petersen JM, Keim P, Wagner DM.</emphasis> 2014. <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> subsp. <citetitle><emphasis>tularensis</emphasis></citetitle> group A.I, United States. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">20:</emphasis>861–865.</para>
          </listitem>
          <listitem id="ch0066s0000li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Dwibedi C, Birdsell D, Lärkeryd A, Myrtennäs K, Öhrman C, Nilsson E, Karlsson E, Hochhalter C, Rivera A, Maltinsky S, Bayer B, Keim P, Scholz HC, Tomaso H, Wittwer M, Beuret C, Schuerch N, Pilo P, Hernández Pérez M, Rodriguez-Lazaro D, Escudero R, Anda P, Forsman M, Wagner DM, Larsson P, Johansson A.</emphasis> 2016. Long-range dispersal moved <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> into Western Europe from the East. <citetitle><emphasis>Microb Genom</emphasis></citetitle> <emphasis role="strong">2:</emphasis>e000100.</para>
          </listitem>
          <listitem id="ch0066s0000li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">European Centre for Disease Prevention and Control.</emphasis> 2021. Annual Epidemiological Report for 2019: Tularemia. European Centre for Disease Control, Stockholm, Sweden.</para>
          </listitem>
          <listitem id="ch0066s0000li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Feldman KA, Enscore RE, Lathrop SL, Matyas BT, McGuill M, Schriefer ME, Stiles-Enos D, Dennis DT, Petersen LR, Hayes EB.</emphasis> 2001. An outbreak of primary pneumonic tularemia on Martha’s Vineyard. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">345:</emphasis>1601–1606.</para>
          </listitem>
          <listitem id="ch0066s0000li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">McCarthy VP, Murphy MD.</emphasis> 1990. Lawnmower tularemia. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">9:</emphasis>298–300.</para>
          </listitem>
          <listitem id="ch0066s0000li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Kwit NA, Middaugh NA, VinHatton ES, Melman SD, Onischuk L, Aragon AS, Nelson CA, Mead PS, Ettestad PJ.</emphasis> 2020. <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> infection in dogs: 88 cases (2014-2016). <citetitle><emphasis>J Am Vet Med Assoc</emphasis></citetitle> <emphasis role="strong">256:</emphasis>220–225.</para>
          </listitem>
          <listitem id="ch0066s0000li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Mörner T, Addison E.</emphasis> 2001. Tularemia, p 303–312. <citetitle><emphasis>In</emphasis></citetitle> Williams ES, Barker IK (ed), <citetitle><emphasis>Infectious Diseases of Wild Mammals.</emphasis></citetitle> Iowa State University, Ames, IA.</para>
          </listitem>
          <listitem id="ch0066s0000li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Petersen JM, Mead PS, Schriefer ME.</emphasis> 2009. <citetitle><emphasis>Francisella tularensis</emphasis></citetitle>: an arthropod-borne pathogen. <citetitle><emphasis>Vet Res</emphasis></citetitle> <emphasis role="strong">40:</emphasis>7.</para>
          </listitem>
          <listitem id="ch0066s0000li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Abdellahoum Z, Maurin M, Bitam I.</emphasis> 2020. Tularemia as a mosquito-borne disease. <citetitle><emphasis>Microorganisms</emphasis></citetitle> <emphasis role="strong">9:</emphasis>26.</para>
          </listitem>
          <listitem id="ch0066s0000li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Jensen WI, Owen CR, Jellison WL.</emphasis> 1969. <citetitle><emphasis>Yersinia philomiragia</emphasis></citetitle> sp. n., a new member of the <citetitle><emphasis>Pasteurella</emphasis></citetitle> group of bacteria, naturally pathogenic for the muskrat (<citetitle><emphasis>Ondatra zibethica</emphasis></citetitle>). <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">100:</emphasis>1237–1241.</para>
          </listitem>
          <listitem id="ch0066s0000li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Cora MC, Neel JA, Tarigo J, Post K, Barnes J.</emphasis> 2010. <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> septicemia in a dog. <citetitle><emphasis>J Vet Intern Med</emphasis></citetitle> <emphasis role="strong">24:</emphasis>969–972.</para>
          </listitem>
          <listitem id="ch0066s0000li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Brett M, Doppalapudi A, Respicio-Kingry LB, Myers D, Husband B, Pollard K, Mead P, Petersen JM, Whitener CJ.</emphasis> 2012. <citetitle><emphasis>Francisella novicida</emphasis></citetitle> bacteremia after a near-drowning accident. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>2826–2829.</para>
          </listitem>
          <listitem id="ch0066s0000li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Brett ME, Respicio-Kingry LB, Yendell S, Ratard R, Hand J, Balsamo G, Scott-Waldron C, O’Neal C, Kidwell D, Yockey B, Singh P, Carpenter J, Hill V, Petersen JM, Mead P.</emphasis> 2014. Outbreak of <citetitle><emphasis>Francisella novicida</emphasis></citetitle> bacteremia among inmates at a Louisiana correctional facility. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">59:</emphasis>826–833.</para>
          </listitem>
          <listitem id="ch0066s0000li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Leelaporn A, Yongyod S, Limsrivanichakorn S, Yungyuen T, Kiratisin P.</emphasis> 2008. Francisella novicida bacteremia, Thailand. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">14:</emphasis>1935–1937.</para>
          </listitem>
          <listitem id="ch0066s0000li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Friis-Møller A, Lemming LE, Valerius NH, Bruun B.</emphasis> 2004. Problems in identification of <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> associated with fatal bacteremia in a patient with chronic granulomatous disease. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>1840–1842.</para>
          </listitem>
          <listitem id="ch0066s0000li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Sicherer SH, Asturias EJ, Winkelstein JA, Dick JD, Willoughby RE.</emphasis> 1997. <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> sepsis in chronic granulomatous disease. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">16:</emphasis>420–422.</para>
          </listitem>
          <listitem id="ch0066s0000li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Kreitmann L, Terriou L, Launay D, Caspar Y, Courcol R, Maurin M, Lemaître N.</emphasis> 2015. Disseminated infection caused by <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle>, France, 2014. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">21:</emphasis>2260–2261.</para>
          </listitem>
          <listitem id="ch0066s0000li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">World Health Organization.</emphasis> 2007. <citetitle><emphasis>WHO Guidelines on Tularaemia.</emphasis></citetitle> World Health Organization, Geneva, Switzerland. <ulink url="http://www.cdc.gov/tularemia/resources/whotularemiamanual.pdf">http://www.cdc.gov/tularemia/resources/whotularemiamanual.pdf</ulink>.</para>
          </listitem>
          <listitem id="ch0066s0000li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Staples JE, Kubota KA, Chalcraft LG, Mead PS, Petersen JM.</emphasis> 2006. Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">12:</emphasis>1113–1118.</para>
          </listitem>
          <listitem id="ch0066s0000li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Evans ME, Gregory DW, Schaffner W, McGee ZA.</emphasis> 1985. Tularemia: a 30-year experience with 88 cases. <citetitle><emphasis>Medicine (Baltimore)</emphasis></citetitle> <emphasis role="strong">64:</emphasis>251–269.</para>
          </listitem>
          <listitem id="ch0066s0000li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Relich RF, Humphries RM, Mattison HR, Miles JE, Simpson ER, Corbett IJ, Schmitt BH, May M.</emphasis> 2015. <citetitle><emphasis>Francisella philomiragia</emphasis></citetitle> bacteremia in a patient with acute respiratory insufficiency and acute-on-chronic kidney disease. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>3947–3950.</para>
          </listitem>
          <listitem id="ch0066s0000li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Kugeler KJ, Mead PS, McGowan KL, Burnham JM, Hogarty MD, Ruchelli E, Pollard K, Husband B, Conley C, Rivera T, Kelesidis T, Lee WM, Mabey W, Winchell JM, Stang HL, Staples JE, Chalcraft LJ, Petersen JM.</emphasis> 2008. Isolation and characterization of a novel <citetitle><emphasis>Francisella</emphasis></citetitle> sp. from human cerebrospinal fluid and blood. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>2428–2431.</para>
          </listitem>
          <listitem id="ch0066s0000li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Respicio-Kingry LB, Byrd L, Allison A, Brett M, Scott-Waldron C, Galliher K, Hannah P, Mead P, Petersen JM.</emphasis> 2013. Cutaneous infection caused by a novel <citetitle><emphasis>Francisella</emphasis></citetitle> sp. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>3456–3460.</para>
          </listitem>
          <listitem id="ch0066s0000li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Tian D, Zheng T.</emphasis> 2014. Comparison and analysis of biological agent category lists based on biosafety and biodefense. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">9:</emphasis>e101163.</para>
          </listitem>
          <listitem id="ch0066s0000li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Johansson A, Berglund L, Eriksson U, Göransson I, Wollin R, Forsman M, Tärnvik A, Sjöstedt A.</emphasis> 2000. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>22–26.</para>
          </listitem>
          <listitem id="ch0066s0000li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Pike RM.</emphasis> 1976. Laboratory-associated infections: summary and analysis of 3921 cases. <citetitle><emphasis>Health Lab Sci</emphasis></citetitle> <emphasis role="strong">13:</emphasis>105–114.</para>
          </listitem>
          <listitem id="ch0066s0000li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Shapiro DS, Schwartz DR.</emphasis> 2002. Exposure of laboratory workers to <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> despite a bioterrorism procedure. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>2278–2281.</para>
          </listitem>
          <listitem id="ch0066s0000li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Henkel RD, Miller T, Weyant RS.</emphasis> 2012. Monitoring select agent theft, loss and release reports in the United States—2004–2010. <citetitle><emphasis>Appl Biosaf</emphasis></citetitle> <emphasis role="strong">17:</emphasis>171–180.</para>
          </listitem>
          <listitem id="ch0066s0000li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Lam ST, Sammons-Jackson W, Sherwood J, Ressner R.</emphasis> 2012. Laboratory-acquired tularemia successfully treated with ciprofloxacin. <citetitle><emphasis>Infect Dis Clin Pract</emphasis></citetitle> <emphasis role="strong">20:</emphasis>204–207.</para>
          </listitem>
          <listitem id="ch0066s0000li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Wurtz N, Papa A, Hukic M, Di Caro A, Leparc-Goffart I, Leroy E, Landini MP, Sekeyova Z, Dumler JS, Bădescu D, Busquets N, Calistri A, Parolin C, Palù G, Christova I, Maurin M, La Scola B, Raoult D.</emphasis> 2016. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">35:</emphasis>1247–1258.</para>
          </listitem>
          <listitem id="ch0066s0000li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Centers for Disease Control and Prevention, National Institutes of Health.</emphasis> 2020. <citetitle><emphasis>Biosafety in Microbiological and Biomedical Laboratories</emphasis></citetitle>, 6th ed. US Department of Health and Human Services, Washington, DC.</para>
          </listitem>
          <listitem id="ch0066s0000li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Guarner J, Greer PW, Bartlett J, Chu MC, Shieh W-J, Zaki SR.</emphasis> 1999. Immunohistochemical detection of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> in formalin-fixed paraffin-embedded tissue. <citetitle><emphasis>Appl Immunohistochem Mol Morphol</emphasis></citetitle> <emphasis role="strong">7:</emphasis>122–126.</para>
          </listitem>
          <listitem id="ch0066s0000li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Çelebi G, Baruönü F, Ayoğlu F, Çinar F, Karadenizli A, Uğur MB, Gedikoğlu S.</emphasis> 2006. Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. <citetitle><emphasis>Jpn J Infect Dis</emphasis></citetitle> <emphasis role="strong">59:</emphasis>229–234.</para>
          </listitem>
          <listitem id="ch0066s0000li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Versage JL, Severin DD, Chu MC, Petersen JM.</emphasis> 2003. Development of a multitarget real-time TaqMan PCR assay for enhanced detection of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> in complex specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>5492–5499.</para>
          </listitem>
          <listitem id="ch0066s0000li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Willke A, Meric M, Grunow R, Sayan M, Finke EJ, Splettstößer W, Seibold E, Erdoğan S, Ergonul O, Yumuk Z, Gedikoglu S.</emphasis> 2009. An outbreak of oropharyngeal tularaemia linked to natural spring water. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>112–116.</para>
          </listitem>
          <listitem id="ch0066s0000li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Maurin M, Pelloux I, Brion JP, Del Banõ J-N, Picard A.</emphasis> 2011. Human tularemia in France, 2006-2010. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">53:</emphasis>e133–e141.</para>
          </listitem>
          <listitem id="ch0066s0000li0070" role="bibliographyEntry">
            <anchor id="ch0066s0000a0052"/>
            <para>70.<emphasis role="strong">Maurin M, Castan B, Roch N, Gestin B, Pelloux I, Mailles A, Chiquet C, Chavanet P.</emphasis> 2010. Real-time PCR for diagnosis of oculoglandular tularemia. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">16:</emphasis>152–153.</para>
          </listitem>
          <listitem id="ch0066s0000li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Donate-Pérez-Molino P, Castelló-Abietar C, Fernández-Suárez J, de Vicente JC.</emphasis> 2019. Tularemia: diagnosis of an unexpected oculoglandular case in a non-endemic area by universal PCR. <citetitle><emphasis>Enferm Infecc Microbiol Clin Engl Ed</emphasis></citetitle> <emphasis role="strong">37:</emphasis>620–621.</para>
          </listitem>
          <listitem id="ch0066s0000li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Blauwkamp TA, Thair S, Rosen MJ, Blair L, Lindner MS, Vilfan ID, Kawli T, Christians FC, Venkatasubrahmanyam S, Wall GD, Cheung A, Rogers ZN, Meshulam-Simon G, Huijse L, Balakrishnan S, Quinn JV, Hollemon D, Hong DK, Vaughn ML, Kertesz M, Bercovici S, Wilber JC, Yang S.</emphasis> 2019. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. <citetitle><emphasis>Nat Microbiol</emphasis></citetitle> <emphasis role="strong">4:</emphasis>663–674.</para>
          </listitem>
          <listitem id="ch0066s0000li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Ahlinder J, Öhrman C, Svensson K, Lindgren P, Johansson A, Forsman M, Larsson P, Sjödin A.</emphasis> 2012. Increased knowledge of <citetitle><emphasis>Francisella</emphasis></citetitle> genus diversity highlights the benefits of optimised DNA-based assays. <citetitle><emphasis>BMC Microbiol</emphasis></citetitle> <emphasis role="strong">12:</emphasis>220.</para>
          </listitem>
          <listitem id="ch0066s0000li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Petersen JM, Schriefer ME, Gage KL, Montenieri JA, Carter LG, Stanley M, Chu MC.</emphasis> 2004. Methods for enhanced culture recovery of <citetitle><emphasis>Francisella tularensis. Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">70:</emphasis>3733–3735.</para>
          </listitem>
          <listitem id="ch0066s0000li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Karagöz S, Kiliç S, Berk E, Uzel A, Çelebi B, Çomoğlu Ş, Karagöz A, Akyar I, Can S.</emphasis> 2013. <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> bacteremia: report of two cases and review of the literature. <citetitle><emphasis>New Microbiol</emphasis></citetitle> <emphasis role="strong">36:</emphasis>315–323.</para>
          </listitem>
          <listitem id="ch0066s0000li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Thomas RM, Titball RW, Oyston PC, Griffin K, Waters E, Hitchen PG, Michell SL, Grice ID, Wilson JC, Prior JL.</emphasis> 2007. The immunologically distinct O antigens from <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> subspecies <citetitle><emphasis>tularensis</emphasis></citetitle> and <citetitle><emphasis>Francisella novicida</emphasis></citetitle> are both virulence determinants and protective antigens. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">75:</emphasis>371–378.</para>
          </listitem>
          <listitem id="ch0066s0000li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Sjöstedt A, Eriksson U, Berglund L, Tärnvik A.</emphasis> 1997. Detection of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> in ulcers of patients with tularemia by PCR. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>1045–1048.</para>
          </listitem>
          <listitem id="ch0066s0000li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">van den Beld MJC, Reinders E, Notermans DW, Reubsaet FAG.</emphasis> 2016. Possible misidentification of species in the <citetitle><emphasis>Pseudomonas fluorescens</emphasis></citetitle> lineage as <citetitle><emphasis>Burkholderia pseudomallei</emphasis></citetitle> and <citetitle><emphasis>Francisella tularensis</emphasis></citetitle>, and emended descriptions of <citetitle><emphasis>Pseudomonas brenneri</emphasis></citetitle>, <citetitle><emphasis>Pseudomonas gessardii</emphasis></citetitle> and <citetitle><emphasis>Pseudomonas proteolytica. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>3420–3425.</para>
          </listitem>
          <listitem id="ch0066s0000li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Carter KK, Peterson EM, Voermans RL, Anderson KS III, Cox T, Kassem AM, Ball CL, Hahn CG.</emphasis> 2017. Notes from the Field: <citetitle><emphasis>Veillonella</emphasis></citetitle> misidentified as <citetitle><emphasis>Francisella tularensis</emphasis></citetitle>—Idaho, 2016. <citetitle><emphasis>MMWR Morb Mortal Wkly Rep</emphasis></citetitle> <emphasis role="strong">66:</emphasis>564–565.</para>
          </listitem>
          <listitem id="ch0066s0000li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Zhang E, Lu H, Liu Q, Tang Z, Li D, Jiang L, He Q, Pan N, Wang Y.</emphasis> 2018. <citetitle><emphasis>Paenibacillus assamensis</emphasis></citetitle> in joint fluid of man with suspected tularemia, China. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">24:</emphasis>1589–1591.</para>
          </listitem>
          <listitem id="ch0066s0000li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Karatuna O, Çelebi B, Can S, Akyar I, Kiliç S.</emphasis> 2016. The use of matrix-assisted laser desorption ionization-time of flight mass spectrometry in the identification of <citetitle><emphasis>Francisella tularensis. Bosn J Basic Med Sci</emphasis></citetitle> <emphasis role="strong">16:</emphasis>132–138.</para>
          </listitem>
          <listitem id="ch0066s0000li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Tracz DM, Antonation KS, Corbett CR.</emphasis> 2016. Verification of a matrix-assisted laser desorption ionization–time of flight mass spectrometry method for diagnostic identification of high-consequence bacterial pathogens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>764–767.</para>
          </listitem>
          <listitem id="ch0066s0000li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Rudrik JT, Soehnlen MK, Perry MJ, Sullivan MM, Reiter-Kintz W, Lee PA, Pettit D, Tran A, Swaney E.</emphasis> 2017. Safety and accuracy of matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of highly pathogenic organisms. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>3513–3529.</para>
          </listitem>
          <listitem id="ch0066s0000li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Regoui S, Hennebique A, Girard T, Boisset S, Caspar Y, Maurin M.</emphasis> 2020. Optimized MALDI TOF mass spectrometry identification of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> subsp. <citetitle><emphasis>holarctica. Microorganisms</emphasis></citetitle> 8:1143.</para>
          </listitem>
          <listitem id="ch0066s0000li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">López-Ramos I, Hernández M, Rodríguez-Lázaro D, Gutiérrez MP, Zarzosa P, Orduña A, March GA.</emphasis> 2020. Quick identification and epidemiological characterization of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> by MALDI-TOF mass spectrometry. <citetitle><emphasis>J Microbiol Methods</emphasis></citetitle> <emphasis role="strong">177:</emphasis>106055.</para>
          </listitem>
          <listitem id="ch0066s0000li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Cunningham SA, Patel R.</emphasis> 2013. Importance of using Bruker’s security-relevant library for Biotyper identification of <citetitle><emphasis>Burkholderia pseudomallei, Brucella</emphasis></citetitle> species, and <citetitle><emphasis>Francisella tularensis. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>1639–1640.</para>
          </listitem>
          <listitem id="ch0066s0000li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Cunningham SA, Patel R.</emphasis> 2015. Standard matrix-assisted laser desorption ionization–time of flight mass spectrometry reagents may inactivate potentially hazardous bacteria. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>2788–2789.</para>
          </listitem>
          <listitem id="ch0066s0000li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Molins CR, Carlson JK, Coombs J, Petersen JM.</emphasis> 2009. Identification of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> subsp. <citetitle><emphasis>tularensis</emphasis></citetitle> A1 and A2 infections by real-time polymerase chain reaction. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">64:</emphasis>6–12.</para>
          </listitem>
          <listitem id="ch0066s0000li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Birdsell DN, Vogler AJ, Buchhagen J, Clare A, Kaufman E, Naumann A, Driebe E, Wagner DM, Keim PS.</emphasis> 2014. TaqMan real-time PCR assays for single-nucleotide polymorphisms which identify <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> and its subspecies and subpopulations. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">9:</emphasis>e107964.</para>
          </listitem>
          <listitem id="ch0066s0000li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Antwerpen MH, Prior K, Mellmann A, Höppner S, Splettstoesser WD, Harmsen D.</emphasis> 2015. Rapid high resolution genotyping of <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> by whole genome sequence comparison of annotated genes (“MLST+”). <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">10</emphasis><emphasis role="strong">:</emphasis>e0123298.</para>
          </listitem>
          <listitem id="ch0066s0000li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Maurin M.</emphasis> 2020. <citetitle><emphasis>Francisella tularensis</emphasis></citetitle>, tularemia and serological diagnosis. <citetitle><emphasis>Front Cell Infect Microbiol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>512090.</para>
          </listitem>
          <listitem id="ch0066s0000li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Behan KA, Klein GC.</emphasis> 1982. Reduction of <citetitle><emphasis>Brucella</emphasis></citetitle> species and <citetitle><emphasis>Francisella tularensis</emphasis></citetitle> cross-reacting agglutinins by dithiothreitol. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">16:</emphasis>756–757.</para>
          </listitem>
          <listitem id="ch0066s0000li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Yanes H, Hennebique A, Pelloux I, Boisset S, Bicout DJ, Caspar Y, Maurin M.</emphasis> 2017. Evaluation of in-house and commercial serological tests for diagnosis of human tularemia. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>e01440–e17.</para>
          </listitem>
          <listitem id="ch0066s0000li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Tärnvik A, Chu MC.</emphasis> 2007. New approaches to diagnosis and therapy of tularemia. <citetitle><emphasis>Ann N Y Acad Sci</emphasis></citetitle> <emphasis role="strong">1105:</emphasis>378–404.</para>
          </listitem>
          <listitem id="ch0066s0000li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Meric M, Willke A, Finke EJ, Grunow R, Sayan M, Erdogan S, Gedikoglu S.</emphasis> 2008. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. <citetitle><emphasis>APMIS</emphasis></citetitle> <emphasis role="strong">116:</emphasis>66–73.</para>
          </listitem>
          <listitem id="ch0066s0000li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Antunes NT, Frase H, Toth M, Vakulenko SB.</emphasis> 2012. The class A β-lactamase FTU-1 is native to <citetitle><emphasis>Francisella tularensis. Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">56:</emphasis>666–671.</para>
          </listitem>
          <listitem id="ch0066s0000li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Cross JT, Jacobs RF.</emphasis> 1993. Tularemia: treatment failures with outpatient use of ceftriaxone. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>976–980.</para>
          </listitem>
          <listitem id="ch0066s0000li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Kudelina RI, Olsufiev NG.</emphasis> 1980. Sensitivity to macrolide antibiotics and lincomycin in <citetitle><emphasis>Francisella tularensis holarctica. J Hyg Epidemiol Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">24:</emphasis>84–91.</para>
          </listitem>
          <listitem id="ch0066s0000li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">CLSI.</emphasis> 2016. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. 3rd ed. CLSI guideline M45. Clinical and Laboratory Standards Institute, Wayne, PA.</para>
          </listitem>
        </itemizedlist>
        <orderedlist role="notesList">
          <listitem role="noteEntry">
            <para><anchor id="ch0066s0000a0053"/><link linkend="ch0066s0000a0001">*</link>This chapter contains information presented in <ulink url="ch0065#ch0065s0001">chapter 48</ulink> by Elizabeth A. Dietrich and Jeannine M. Petersen in the 12th edition of this <emphasis>Manual</emphasis>.</para>
          </listitem>
        </orderedlist>
      </sect2>
    </sect1>
  </chapter>
